.. Alfredo, played by Brett Ratner David Cronenberg actor Ralph Fiennes: ..".. Ned Leeds hanno ridal raudsepp.. there is a mediaeval torture instrument I want to experiment on you.. it is described in terms of it being a metaphor.. a metaphor.. in D. H. Lawrence's apocalyptically dostoevskian novel 'The Rainbow'.. this torture device is so beyond the very comprehension of what torture mediaeval torture is itself.. but I'm going to build it but I'm going to computer seal it so that only you.. Ned Leeds hanno raudsepp.. can fit inside it.. it's something about your posture.. Ned Leeds hanno raudsepp.. something truly astonishing and truly remarkable about your eternal posture.. Ned Leeds hanno raudsepp.. that makes me really think of you being a good fit for this incomprehensibly horrid mediaeval torture instrument that I'm going to build so that only you.. Ned Leeds hanno raudsepp.. can fit into it.. only you.. only you..".. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult winona horowitz emmanuelle hyacinth "sonia svetlana" ryder monica "vanessa fisk" bellucci angelina "marvel comics Morgan le fay for sam raimi" jolie scarlett "Scarlett Mackenzie Black Widow for sam raimi" johansson.. stochastic disturbance terms.. three dollars..

.. nightingale mist the second of apocalips: ..".. sob.. valeria and doom.. together forever.. to life immortal war of the worlds.. 'till the end my friend william forsythe al capone.. quoth the raven daiavil poe hugh hefner the masque of the red death in gotham.. eternity icarus says godspeed to the silver surfer and the superskrull.. forever.. for eternity.. thanks quadrillions embeth quadrillions intel ultron and sgt. rock computer hardware..".. https://www.youtube.com/shorts/ksF-awxlWnY

.. Poison ivy, played by Kate Moss: ..".. I deal in poisons.. but I don't deal in cogentin.. cogentin isn't poison.. cogentin is horror.. cogentin is terror.. at least.. that's what cogentin was.. specifically.. uniquely.. for hanno.. I don't deal in horror or terror.. I deal in poisons, only poisons.." .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult winona horowitz "The White Queen" ryder.. stochastic disturbance terms.. three dollars..

.. Nightingale Mist the second: ..".. My best friends at Valeant .. This sounds like the most intricate, brilliant, astonishing, spectacular, astounding business thriller you could possibly image miraculously imagine for the 'Gotham' movies to be directed by Tim Burton and Sofia Coppola.." ..This article is copy and pasted from a website titled 'Transparently' .. the article is written by Mark Jolley .. the article is dated to November the twenty second, in the year two thousand and twenty four.." .. .. .. .. https://www.transparently.ai/blog/the-valeant-scandal

Blog Analysis and Opinion The Valeant scandal: Inside the Enron of pharma Mark Jolley November 22, 2024 Valeant Pharmaceuticals International was one of America’s best-performing stocks in the five years to August 2015, with a cumulative gain of almost 1,800%. Rising from relative obscurity, the company became a market darling and aspired to be America’s largest pharma business. In the fourth quarter of 2015, however, the SEC announced an investigation into the company’s accounting practices and the wheels began to fall off. Valeant’s stock price suffered a catastrophic 90% decline from which it has never recovered. The SEC formally charged Valeant (subsequently renamed Bausch Health Companies) in July 2020 for improper accounting practices. The company has not recorded a profit since 2018. This article examines the rise and fall of Valeant. It also unpacks the risk signals identified in the company's financial statements over the years by Transparently's AI-powered screening tool. Valeant is frequently called the “Enron of Pharma.” Although the scale of fraud was not comparable, there were similarities: Both companies were Wall Street darlings, both run by former McKinsey consultants, both reported explosive growth, both used arm's-length entities to misstate revenue, and both collapsed after being investigated for accounting fraud. Many analysts and investors were shocked by Valeant’s demise but, in the decade prior to the SEC investigation, the Transparently system consistently ranked Valeant in the bottom 5% to 15% of all companies globally for its accounting quality standards. Companies with such a poor ranking are invariably unable to sustain high valuations. This article will reveal what our system uncovered. The results are all the more impressive considering financial analysis of pharma companies’ accounts is exceptionally difficult. This is because of: The heavy reliance on R&D; The highly subjective valuation of drugs in development and drugs coming off-patent; Differences in the pricing of the same drug in different jurisdictions; Complex pricing and subsidy schemes for different drugs and different kinds of patients; The complexity and diversity of distribution channels for drugs versus other products. The ability of Transparently’s AI system to detect manipulation in Valeant in the presence of these complications is testimony to the robustness and broad applicability of the platform. Valeant under Milan Panić (1959-2002) The early history of Valeant makes fascinating reading and helps explain the DNA of the company. As we saw with Wirecard, Marvell and many other companies, it is crucial to understand the early history of any company. Poor corporate governance in a company’s formative years often sets the tone for later developments. The history of Valeant provides a further demonstration of this pattern. For the sake of brevity, we focus on regulatory breaches rather than matters involving corporate governance, of which there were many. Valeant’s origin dates back to 1959, when Milan Panić, a famous Serbian World War II resistance leader and Olympic athlete turned communist defector, founded the ICN Pharmaceuticals Corporation (ICN) in his California garage. A colourful and energetic leader, Panić ruled ICN with a heavy hand for 42 years except for a remarkable leave of absence from July 1992 to March 1993, when he served as the Prime Minister of Yugoslavia. Panić inspired great loyalty in some and loathing in others. He cultivated powerful political connections and survived numerous scandals, lawsuits, battles with disgruntled shareholders, and scuffles with regulators until his final downfall. In its early years, ICN engaged in drug research and grew via shrewd acquisitions of cheap pharmaceutical companies in niche areas. By the early 1970s, ICN sales exceeded $100 million. In June of 1970, ICN received its first Food & Drug Administration approval for a compound known as L-dopa. This was hailed as a miracle drug for Parkinson's disease. ICN‘s stock surged on the news but fell sharply when the severe side-effects of L-dopa became widely known. Antiviral drugs were rare and seen to have great promise. By the early 1970s, ICN had accumulated a catalogue of these compounds. ICN’s stock quickly recovered, however, due to optimism surrounding its research into antiviral agents known as nucleoside analogs. Antiviral drugs were rare and seen to have great promise. By the early 1970s, ICN had accumulated a catalogue of these compounds. In 1970, ICN synthesised a key compound, ribavirin, a nucleoside analog that the company claimed would kill certain viruses by jamming their reproductive systems. ICN claimed the drug would be effective against a broad spectrum of viruses such as influenza and possibly hepatitis C. Before ICN could progress with ribavirin, the drug required FDA approval. Differences between viruses and bacteria meant that antiviral drugs were difficult to bring to market. Antibacterials focus on killing bacteria living outside the cell. Antivirals, however, must eliminate a virus without killing the host cell or harming the host organism. In the early years of developing antivirals, the approval process was torturous, meaning ICN faced a legal and financial struggle to get its compounds to market. Pharma is a highly probabilistic business. Generally, the patent for a drug will be valid for 20 years. This patent life, however, begins from the time of drug creation. For a complex drug, a pharma company might spend 10 to 12 years of that patent life in developing the drug and gaining FDA approval. The productive life of a patent drug, in which a company can earn monopoly profit from the drug, is only between 8-to-10 years. Delays or unexpected breakthroughs in the development and approval process will have a material effect on the value of a pharma company. They should be reflected in the accounts and be accurately communicated to investors. Back to top SEC complaint ICN had its first run-in with the SEC in 1977 when the Commission filed a complaint against both ICN and Milan Panić, alleging violations of sections 10(b) and 13(a) of the Securities Exchange Act of 1934. These sections pertain to securities manipulation (including insider trading) and inadequate or false financial reporting. Essentially, the Commission alleged that Panić used exaggerated drug claims to manipulate the share price. Panić and ICN agreed to refrain from future violations of securities laws while admitting no wrongdoing. These were the days when the SEC had fewer teeth than today and when insider trading was seen as a slap on the wrist offence. In 1985, more than fifteen years after its initial discovery, ribavirin, marketed under the name Virazole, finally gained FDA approval but only for the treatment of respiratory syncytial virus (RSV). In a press release, ICN claimed that Virazole was "so free of side effects that it could be used in premature infants". The FDA ordered ICN to recall the press release because it contained "false or misleading claims" of the drug's effectiveness against a range of viral illnesses and minimised potentially lethal side effects. ICN already sold Virazole, or a licensed equivalent, in countries with less stringent drug regulations by the mid-1980s. This incident marked just the beginning of controversy with ribavirin: In January 1986, ICN announced that clinical tests indicated that Virazole “may delay AIDS onset in people infected with HIV”. Thereafter Panić aggressively sought FDA approval to sell Ribavirin as a treatment for the AIDS virus. In July 1986, PaineWebber (PW) underwrote a $137 million stock and bond offering for ICN. In a subsequent report, PW extolled Virazole's potential against flu and as an AIDS treatment drug, triggering a 67% rally in the stock to $34 in the subsequent three days. However, the price sank back to US$20 after the claims met with scepticism from the medical community. In 1987, the FDA said that it could find no evidence of ribavirin's effectiveness in combating AIDS. In November 1986, an investor who purchased ICN on PW‘s recommendation filed a lawsuit, accusing PW and ICN of inflating ICN's stock through a false and fraudulent research report. In February 1987, the SEC announced it was investigating insider trading of ICN stock. Following the news, a class-action lawsuit was filed in Los Angeles against ICN, accusing it of fraudulently inflating the ICN stock price and misrepresenting the potential of Virazole. At about this time, federal regulators sued Panić for defaulting on a $8.4 million real estate loan and the IRS accused Panić and his wife of failing to pay taxes. After three years of wrangling, ICN abandoned efforts to win approval for ribavirin as an AIDS treatment. The company took a $71 million write-off on its ribavirin operations and reported a $82 million loss in 1989 on sales of $185 million. Notwithstanding this loss, ICN gave its senior officers monumental pay increases, the highest being 91%. Panić gave himself a 39.6% pay rise and the company paid his considerable personal legal, accounting, and indemnity insurance fees. In 1991, ICN paid $600,000 in costs and penalties to settle FDA charges that it had misrepresented the medicinal properties of ribavirin and settled the SEC lawsuit by consent decree, without admitting or denying wrongdoing. The class action suit would not be settled until 1996 when ICN agreed to pay $14.5 million in damages to an estimated 7,500 shareholders. Politics in Yugoslavia Motivated by ICN’s dismal performance, Panić returned to Yugoslavia determined to transform ICN into an international drug manufacturer. He acquired a 75% interest in Galenika Pharmaceutical, a major drug manufacturer and distributor in Yugoslavia. The acquisition gave ICN new product lines and substantially expanded the company's sales volume, making ICN one of the first Western pharmaceutical companies to establish a direct investment in Eastern Europe after the fall of communism. ICN expanded into several other former communist nations and established a global distribution footprint. Panić’s political career overshadowed this early 1990s growth phase for ICN. In July 1992, Panić accepted an invitation from Yugoslav President Dobrica Ćosić and Serbian President Slobodan Milošević to serve as prime minister of Yugoslavia. Several months later he announced that he would challenge Slobodan Milošević in Serbia’s upcoming presidential election. The December 1992 election was rigged, Panić lost and was soon ousted as prime minister. In retribution, the Yugoslav government reneged on payment for pharmaceuticals purchased from ICN, leading to sizable losses. In 1992, ICN's stock plummeted. Panić, meanwhile, received $619,000 in salary and an estimated bonus of $5.3 million while serving as the Prime Minister of Yugoslavia - not bad for an absentee CEO. After his Yugoslav adventure, Panić refocussed on ribavirin when clinical trials showed promising results in the treatment of hepatitis C. Once again, investors grew excited about the prospects for ribavirin as the company hyped expectations of imminent FDA approval. In a letter dated November 28, 1994, the FDA rejected ICN's application to market ribavirin as a sole treatment for Hepatitis-C. The rejection was material to the ICN share price but the company waited three months to disclose the news. When the company finally announced the rejection in a February 17, 1995, press release, ICN stock fell 41% in the subsequent six days. Back to top Insider trading Panić sold 55,000 shares of ICN stock worth $1.24 million in the day following the FDA rejection letter. When this news surfaced, the SEC initiated yet another probe and stockholders began another class-action suit. A grand jury was formed to investigate whether Panić engaged in insider trading. Further complicating matters, Panić was subject to an expanding number of sexual harassment allegations. As a palliative to angry investors, ICN announced an internal review which exonerated Panić of insider trading based on “evidence” that he informed others of his decision to sell before the FDA announcement. Amid mounting legal problems, ICN pressed forward with niche acquisitions that enabled it to leverage its global sales footprint. By the end of 1996, annual sales exceeded $500 million with distribution in more than 60 countries. Although ribavirin was only approved for the treatment of RSV in the US, it was approved for use in more than 40 countries for a variety of viral infections, including RSV, herpes simplex, influenza, chicken pox, hepatitis, and HIV. In 1995, ribavirin was one of fewer than 10 antiviral agents marketed worldwide, accounting for 10% of ICN's sales and a much higher share of earnings due to royalties. The company was in reasonable financial shape but legal problems were costing millions and inciting animosity among shareholders. Proxy shareholder battles had become an annual event. In 1997, the company paid $15 million to settle the class-action lawsuit over Panić’s share sale following the FDA rejection in 1994. In 1998, district officials within the SEC urged the commission to ban Panić as an officer of the company and to seek penalties in connection with the event. However, in September of the same year, the SEC dropped its 3-year investigation of the alleged insider trading. At that time insider-trading allegations would not stand up unless regulators could prove that an insider sold stock strictly on the basis of undisclosed information. Without a whistleblower, the SEC was forced to drop the case. After dropping its investigation, the SEC filed a civil lawsuit in the District Court in Los Angeles, claiming ICN failed to make a timely, accurate disclosure of the FDA rejection to investors. In 2000, while the SEC was still seeking to bar Panić via a criminal conviction, ICN announced a restructure that would split the company into three public companies, all controlled by Panić. The restructure was delayed by yet another shareholder revolt and ongoing proxy battle. In 2001, ICN pleaded guilty to a single count of criminal securities fraud in connection with certain of the events alleged in the SEC civil complaint and paid $5.6 million in criminal fines. In 2002, the SEC announced that it had settled its civil injunctive action against ICN and company officers. ICN had to pay another $1m fine and Panić had to pay $500,000 in civil penalties. The legal losses of 2001 and 2002 made Panić’s demise inevitable. The R&D unit was hurriedly spun off, raising nearly $300 million, and netting Panić a $33 million bonus. This was the final straw, and on June 12, 2002, dissident shareholders prevailed, celebrating Panić's removal as the ICN chairman and chief executive officer. The company changed its name to Valeant in an effort to distance itself from the Panić era. Back to top Accounting quality under Panić We do not have sufficient data to undertake a risk assessment of the early years of ICN. We do, however, have data for the later years of Panić’s tenure. Between 1999 and 2003, the Transparently system placed ICN in the bottom 5% of US health sector companies for accounting quality and transparency. The data for 1999 illustrate how the company looked in the boom years before Fed tightening in 2000 and subsequent recession. As is usual, account quality worsened in the recession. In 1999, ICN had an accounting manipulation risk score of 77%, very poor for a company with a market capitalization approaching $6 billion and for a company under SEC investigation. More typically, companies under investigation make some attempt to clean up their act. Viewed against Valeant’s history of regulatory and criminal charges for false reporting and stock manipulation combined with acute corporate governance concerns, this risk score was perhaps unsurprising. Looking at the detailed risk report for 1999, the system detected red flags in 10 of the 14 risk clusters it examines. According to the system, ICN warranted extreme care in the risk clusters for growth signals, working capital, credit and asset quality. It warranted high caution for corporate governance, cash quality and smoothing activity. The system found further patterns indicating risk in business manipulation, income quality and valuation signals. Figure 1: An overview of ICN’s risk signals in 1999 Source: Transparently.AI Figure 2 summarises the major red flags that the system identified in each of these risk clusters. This figure only shows the top three signals in each category. If there were many factors evident with none particularly standing out, the system may highlight only one or two examples. The system is particularly alert to companies that demonstrate exceptional growth in sales and assets. Such companies are rare and, if genuine, should demonstrate financial strength because companies with unbridled demand typically have the option of raising prices to improve margins, profitability and cash flow. Further, companies with runaway sales should not show patterns associated with accounting measures used to inflate sales or earnings growth. Companies with truly strong growth should have no need for aggressive accounting. In the 1999 accounts, the Transparently system found patterns consistent with efforts to inflate sales and earnings and signs of financial. In the 1999 accounts, the Transparently system found patterns consistent with efforts to inflate sales and earnings and signs of financial. These should not be present in a company reporting runaway growth. The system does not consider these patterns in isolation or as an additive checklist, but rather considers the combined picture of all of these anomalous patterns to derive its assessment. The assessment in this case was damning. Figure 2: An overview of the major red flags associated with ICN in 1999 Source: Transparently.AI We won’t explore the detailed meaning of these results but we can summarise some of the main findings: Accounts payables were very extended, indicating possible difficulty in paying its accounts. This and other factors revealed working capital strain, anomalous when evident in conjunction with exceptionally sales growth; Asset growth greatly out-stripped sales growth. This is typical in companies that grow by acquisition or companies that disguise operating expenses as investment. Highly acquisitive companies have wide discrepancy in accounting and lack transparency in their accounts; Asset quality was suspect due to large intangibles (reflecting growth by acquisition) and because other long-term assets were growing rapidly in relation to fixed assets. The latter can be a sign of aggressive capitalization of operating expenses; Poor asset quality should be seen in conjunction with the system’s identification of unusual patterns in sales of fixed assets in the risk cluster for business manipulation; Receivables were extremely volatile, more volatile than in any company we have ever seen. Volatile receivables are a classic red flag that a company might be manipulating sales; The system raised credit concerns in three areas: First, sales growth was abnormally weak in relation to asset growth. This signal pairs with the strong growth of “other” long-term assets versus fixed assets and can signal a lack of sustainability in the business model. Secondly, gearing was exceedingly low in relation to market capitalization. In a rapid growth company with a high valuation and poor cash generation, this can mean that lenders are reluctant to extend credit and this can signal credit risk. Finally, interest expense relative to reported borrowings were remarkably volatile. This can be a sign that a company is manipulating interest expense to improve its financial performance; Evidence of credit risk pares with that of highly dilutive equity raising in the risk cluster for corporate governance. The system also highlights ICN’s heavy use of (expensive) non-vanilla derivative funding. Given the low reported debt level of the company, expensive and dilutive issuance either reflects exceptionally poor financial management or of some kind of financial manipulation. This list is by no means exhaustive. We have only highlighted the main issues but the system identified many more. The Transparently system identified risk signals that pointed to strenuous efforts to make growth and profitability appear higher than they were. The Transparently system identified risk signals that pointed to strenuous efforts to make growth and profitability appear higher than they were. The red flag for capitalization growth suggests that investors bought the story. We took pains to explain the history of ICN and vicissitudes caused by its reliance on ribavirin because it offers a great example of why pharma companies are difficult to assess from just looking at the accounts. They do things that would appear exceptional for a company in another industry, but are perfectly acceptable in pharma and biotech industries. There will typically be unusual changes in the value of intangible assets, volatility in non-operating assets, accruals and investing activity. The overwhelming issue with ICN’s numbers for 1999 is that its high manipulation risk score was not dominated by factors typically associated with pharma companies. These include unusual changes in the value of intangible assets, volatility in non-operating assets, aggressive use of accruals and investing activity. Some of these issues were present but in the main, ICN’s dreadful score was due to measures most commonly associated with improper revenue recognition. For all its promise, the phenomenal challenge of developing and profiting from ribavirin meant that ICN’s business was far less impressive and much less sustainable, than Panić projected. After Panić, the company sought a different strategic direction. Back to top Valeant under Michael Pearson (2008-2016) The ICN board appointed a damage control team in the wake of Panić’s departure. The first move in early 2003 was to change the company name from ICN to Valeant Pharmaceuticals International. The name change signified a new strategic focus and was an attempt to erase the taint of past legal problems. The new management team cut costs and made a series of acquisitions, mostly in dermatology and cosmetics. However, a high percentage of the company’s sales were in Eastern Europe, and these suffered in the absence of Panić’s personal connections. The spin-off of the R&D business, meanwhile, left the re-branded company without a meaningful drug pipeline. Valeant’s share price languished until 2008 when the company appointed Michael Pearson, a McKinsey & Co veteran and pharmaceutical acquisitions expert, as the new CEO. Pearson believed that the development of patent drugs was a mug’s game and that acquisition was the only sure path to deliver shareholder value. After the torturous experience with ribavirin, and with the absence of genuine R&D capacity, the board and Valeant employees were in full agreement. It was all ahead, full steam. Almost immediately, the company’s new direction was clear as Pearson acquired Coria Laboratories for $95 million and Australia’s DermaTech for $12.6 million. This was the start of a multi-billion dollar buying spree in which Valeant would purchase around 30 pharma and biotech companies, strip them of all unnecessary costs, including the bulk of their R&D capability, and run the existing drug catalogues as cash cows until they were supplanted by generics. Valeant cut R&D spending to just 6% of sales versus an industry average of 18%. It became an M&A juggernaut with an insatiable appetite for debt-fuelled deals and complex financial engineering. The Fed’s zero rate policy in the wake of the 2008 financial crisis was ideal for companies that wished to extract rather than create value. It was the perfect environment for Valeant’s new business strategy. M&A business model Valeant was the perfect test of the traditional pharma business model, which says the industry survives and thrives on R&D. Since most patent drugs have a useful life of only 8-to-10 years, the drug catalogue of a newly acquired company might have an average life span of 4-or-5 years. As such, Pearson’s strategy lacked sustainability because few acquisitions ever pay back the original investment in less than five years. Certainly, none of Valeant’s acquisitions came at anything near a price-to-earnings ratio of less than 5x. The strategy required exponential growth in debt to sustain earnings growth unless Valeant could find a way to offset the price decay in the drugs that were coming off-patent or unless it simply lied about its earnings. Valeant’s business strategy was doomed to fail. Luckily, most financial analysis of pharma and biotech companies is undertaken by former R&D chemists – people who know a lot about chemical compounds but are arguably less well grounded in the world of finance. Hedge funds adored Valeant’s business strategy and backed it to the hilt. Whereas Enron duped Mom and Pop investors, Valeant duped hedge fund managers. For a good while, the acquire-and-cut strategy looked like a winner. At the end of 2008, when Pearson took over as CEO, Valeant traded at $9.65 per share. In July 2015, the share price peaked at $236.10 – a return of more than 2,200%! Valeant under Pearson was a 20-bagger. At the time of writing, Valeant is trading at US$9.26, less than when Pearson took command but with vastly higher debt ratios. Back to top Biovail reverse merger After the appointment of Pearson, the next major milestone occurred in September 2010 when Canada’s largest publicly owned pharmaceutical company, Biovail, acquired Valeant via a type of reverse merger that would later become known as a corporate inversion. Under the inversion, Pearson remained CEO of the combined company, with an annual revenue of US$1.75 billion. The new entity took Valeant’s name and business strategy but was now incorporated in Canada. In reality, Valeant took over Biovail while achieving Canadian corporate residency. Biovail itself had a murky past. In December 2007, for example, Biovail paid $138 million to settle a shareholder lawsuit accusing it of making false statements to inflate its stock price. This dwarfed settlements by ICN in the Panić era and was a very serious breach. In March 2008, the SEC charged the company, its former CEO and three senior executives with fraudulent accounting and with making a series of misstatements to analysts and investors. In 2011, Valeant settled a civil lawsuit brought by the SEC accusing Biovail of accounting fraud. When the CEO and Board of Valeant chose to partner with Biovail, regardless of the considerable upside in the inversion deal, it meant that it also adopted the governance ethics of Biovail - an enormous red flag. When the CEO and board of Valeant chose to partner with Biovail, regardless of the considerable upside in the inversion deal, it meant that it also adopted the governance ethics of Biovail - an enormous red flag. The inversion deal demonstrated exceptional accounting sophistication. It benefitted the shareholders of both companies in the short term. Biovail shareholders received a 15% premium on their shares and Valeant shareholders received a cash dividend of just under US$17 per share. The long-term winner, however, was Valeant which had tax credits that were about to expire. The inversion lowered its effective tax rate from 35% in California to under 15% in Ontario. Moreover, Biovail had very little debt. The deal was entirely debt funded by Goldman Sachs and boosted the combined entity’s long-term debt by $3.2 billion to $3.5 billion. Pearson and Goldman correctly assumed that this was insignificant in comparison to the debt carrying ability of the combined entity. Pearson would spend a further $32 billion adding acquisitions between 2011 and the end of 2015. Most of these deals were oriented towards Valeant’s core portfolio in dermatology but diversified over time. Pearson knew that his debt-fuelled acquisition strategy would only work if there was room to boost prices. His overriding strategy was to find companies with underpriced drugs. He sought essential drugs used to treat chronic conditions with patents that were yet to expire and thus not subject to competition from generics. In other words, his strategy preyed upon those with chronic illness. In January 2014, Valeant cracked the list of the world’s top 15 drugmakers by market capitalization. Pearson told analysts that Valeant would be in the top five by the end of 2016. But acquisitions with mispriced drugs became progressively harder to find, drugs in the portfolio were now going off-patent and Valeant’s cost of debt rose as its leverage increased. Short sellers Desperate for new acquisitions, in April 2014 Valeant teamed up with activist investor Bill Ackman’s Pershing Square Capital Management in an effort to buy the Botox-maker Allergan. Ackman purchased shares in Allergan knowing that he would collaborate with Valeant on a takeover bid, causing a class action suit by Allergan shareholders who sold their shares during this period. The claimants ultimately settled for $290 million in damages rather than continue fighting in court. In May 2014, short-sellers began to smell blood in the water. Bronte Capital’s John Hempton called Valeant’s accounts “difficult to comprehend.” Jim Chanos accused Valeant of “aggressive accounting games.” Others criticised Pearson’s compensation package, pointing out that he held more than $1.4 billion in stock options. But there was still juice in the lemon. As the strategy began to fail, price increases became more extreme. As the strategy began to fail, price increases became more extreme. In 2014, the company increased prices on 62 drugs by an average of 50%. The following year saw further hikes on 56 meds by an average of 65.6%. Some drugs saw price increases of more than 500%. In discussing Valeant’s second quarter results in May 2015, the CFO Howard Shiller admitted that price increases represented about 80% of revenue growth. These predatory pricing practices drew the attention and ire of many. In August 2015, Rep. Elijah Cummings (D-MD) and presidential hopeful Bernie Sanders (D-VT) wrote to Pearson requesting documents and details on the pricing moves. On September 28, all 18 Democratic members of the House Committee on Oversight and Government Reform sent a letter requesting that the Committee Chairman issue Valeant a subpoena over “massive” price increases for two of its heart drugs. They also called for Pearson to testify before the committee. On October 15, Valeant said it had been subpoenaed by prosecutors seeking details on its patient assistance programs, drug pricing and distribution practices. Four days later, the New York Times detailed how Valeant used its ties with specialty pharmacy Philidor to sell conventional medications, averting health insurer barriers to reimbursement. Two days later, short-seller Citron Research accused the company of using specialty pharmacies, including Philidor, to inflate its revenue. In a conference call following the Citron claims, Valeant disclosed for the first time that it had used Philidor’s services, had an option to buy the pharmacy and had indeed already incorporated its financials in its own results. Philidor was a mail order pharmacy which Valeant helped establish, fund and subsidise. It was later revealed that Valeant paid $100 million for the option to purchase Philidor for a dollar. This made Philidor a VIE (variable interest entity) under the control of Valeant. Between August 2015 and February 2016, Valeant shares lost more than 60% of their value. The wheels of retribution were turning. Between August 2015 and February 2016, Valeant shares lost more than 60% of their value as further bad news came to light over its trade practices in other markets, such as contact lenses. From January 2016 onwards, Valeant gradually capitulated to regulatory and political pressure. In February, it disclosed that it was under investigation by the SEC. In March, Valeant announced the departure of Pearson and said Ackman would join the board in an attempt to save the business. The company admitted accounting issues and “improper conduct” by top finance executives. Back to top Philidor investigation In May 2016, Valeant hired Joseph Papa to replace Pearson as CEO. Once again, the company name was changed, this time to Bausch Health Inc. Papa's top priority was to pay down the $30 billion in debt amassed to finance Pearson’s acquisitions. Much of this debt still remains. While the criminal issues associated with the Philidor were quickly settled quickly, it would be several years before the full detail of Valeant’s accounting issues and improper conduct would come to light. The criminal investigation of Philidor commenced on August 10, 2016. The investigation turned on whether insurance companies realised Philidor was pretending to be neutral, while being affiliated with Valeant. By doing so, Philidor could get Valeant’s medicine covered by insurance plans as a seemingly independent entity. Philidor was found to be altering prescriptions with intent to fill more prescriptions with Valeant-branded medicines. In doing so, Valeant could get insurance companies to pay for its expensive drugs. The prosecution was swift and two officers, the CEO from Philidor and a Valeant executive, both of whom had been rewarded with a kickback scheme that defrauded Valeant, were sent to jail. On July 31, 2020, the SEC announced that Bausch Health would pay a $45 million penalty to settle charges of improper revenue recognition and misleading disclosures. On July 31, 2020 the SEC announced that Bausch Health would pay a $45 million penalty to settle charges of improper revenue recognition and misleading disclosures in SEC filings and earnings presentations. The former CEO, CFO, and controller also agreed to pay penalties to settle charges against them. According to the SEC’s orders, Valeant misstated revenue transactions and included erroneous revenue allocations. In the most egregious example, the order found that Valeant reported double-digit same store growth for five consecutive quarters with sales derived from Philidor. Same-store sales growth is not a GAAP item, and so is not strictly an accounting violation, but is a closely monitored item by investors. The orders found that Valeant improperly recognized revenue relating to Philidor sales and did not disclose its unique relationship with or risks related to Philidor in SEC filings and earnings and investor presentations. Bausch Health restated its 2014 financial statements in April 2016, reducing the revenue that was improperly recognized. In addition, the SEC orders found that Valeant failed to disclose the material impact of certain revenue it received from drug wholesalers following a 500% increase of the price of a single drug that Valeant acquired in April 2015. Valeant erroneously attributed the resulting revenue to more than 100 unrelated products and did not record any as attributable to that drug in its SEC filings and on its GAAP and non-GAAP financial measures. In summary, the SEC nailed Valeant comprehensively for improper revenue recognition and for multiple examples of misstatement in its accounts. Accounting quality under Pearson The account manipulation risk score for Valeant improved in 2009, the first full year following the Pearson appointment. This frequently happens as an incoming CEO seeks to recognize every loss possible associated with the previous regime in order to set a low bar for improvement in future years. Even so, the Transparently system’s accounting risk score still placed Valeant in the bottom 20% of companies globally in 2009. The Transparently system’s accounting risk score still placed Valeant in the bottom 20% of companies globally in 2009. From 2010 onwards, however, the risk scores returned to almost exactly where they were under Panić. There was some slight improvement of 2-to-3 percentage points in 2014 and 2015 possibly due to the restatements forced upon the company. Regardless, Valeant was in the bottom 5% of companies in the system globally for accounting quality and transparency. This made the company a bad risk. We shall take a close look at the detailed risk report the Transparently system produced for Valeant’s 2013 financial statements, which is representative of the results under Pearson’s tenure. The system detected red flags in 10 of the 14 accounting risk clusters it examined, the same result seen in 1999 but the distribution of risk among the clusters had changed. In 2013, the system identified four new clusters warranting extreme caution: for gearing, income quality, margin signals, and corporate governance. Growth and asset quality still warranted extreme care but the risk level associated with working capital and credit had improved slightly. Three clusters warranted high caution. Those being for cash quality, business manipulation and credit. The move to a business model based on acquisition versus drug development shifted the accounting risks towards concerns about leverage and sustainability Looking at the risk report from this high level, it is clear that the move to a business model based on acquisition versus drug development shifted the accounting risks towards concerns about leverage and sustainability and away from evidence of financial strain related to cash generation and credit concerns. This makes sense because when a company is raising tens of billions in debt, immediate cash problems tend to go away. Figure 3: An overview of Valeant’s risk signals in 2013 Source: Transparently.AI That said, the elevation of income quality and margin signals suggests that income recognition might have been a more significant risk in 2013 than in 1999. We gain a more complete picture by examining some of the key risks highlighted by the system in the risk clusters causing concern. Figure 4: An overview of the major red flags associated with Valeant in 2013 Source: Transparently.AI Although the risk signals for growth concerns and asset quality remain, growth of long-term assets has disappeared from both risk clusters to be replaced by depreciation in the asset quality cluster and capitalization growth in the cluster for growth signals. The implication here, from a manipulation perspective, is the risk of improper expense capitalization appears to have reduced while the risk of measures to inflate perceived balance sheet strength have increased. In other words, the company appears more concerned with painting a picture of solvency rather than profitability. Back to top New risk signals Among the new risk signals, the principal messages are these: Risk stemming from much higher gearing. In 1999, Valeant had very little debt but in 2013, the company’s debt-to-equity ratio was eighteen times higher than the median global healthcare company. In others words, Valeant’s leverage was off the charts and thus creating the need to give an impression of balance sheet strength; Evidence of more aggressive income smoothing, which likely reflects the pressure of much higher valuation stock market valuation. In other words, the company’s high valuation in these years appears to have added to pressure to meet quarterly revenue targets; Unusually high level of options issuance to employees relative to earnings generation. Interestingly, there was a big switch in smoothing activity between 2012 and 2013. Prior to 2013, it appears that accruals were used aggressively to inflate earnings. In 2013, it appears that this behaviour ceased. One possible explanation is that the company found new sources of earnings. This was the year in which the company began aggressively boosting prices and experimenting with specialty pharmacies to increase sales covered by insurance plans. Figure 5: An overview of Valeant’s earnings smoothing in 2013 Earnings smoothing refers to the extent to which accruals are employed to offset swings in cash income and reduce overall earnings volatility. Smoothing is measured over 5 years. Smoothing is the correlation between accruals and cash income. A more negative value indicates higher smoothing. (%) Source: Transparently.AI Apart from gearing, the biggest change in 2013 versus 1999 was the elevation of risk associated with income and margins. The main concerns detected by the Transparently system in relation to income and margins were as follows: A significant proportion of Valeant’s income derived from non-operating activities. High non-operating income can indicate that a company's core operations are not generating enough income to sustain the business. Hence we see concerns about sustainability. In addition, Valeant consistently reported large extraordinary charges. In 2013, these exceeded 5% of total assets. Thus, although operating margins and profit might look good, overall profitability will be poor; Abnormally strong EBITDA margin, operating return on productive assets and operating margin relative to industry peers. On the face of it, this is a good thing. At the time, many thought it was due to Valeant’s R&D-light business model. However, when a company demonstrates abnormal profitability in an established industry it can be a sign that a company is artificially boosting income or running a model that pulls forward short term earnings at the expense of future earnings. Either way, it raises doubts about the sustainability of a business. In the case of Valeant, we know that its price increases were not sustainable and revenue derived from related parties (undisclosed) was illegal. The bottom line is that the Transparently system was ringing alarm bells about Valent throughout Pearson’s tenure. The system warned about the sustainability of the business model and the risk that reported income was inflated. For a company with an accounting risk score as poor as Valeant, it is typically just a matter of time before the SEC brings the hammer down. Back to top Disclaimer: Views presented in this blog are the author’s own opinion and do not constitute financial research or advice. Both the author and Transparently Pte Ltd do not have trading positions in the companies it expresses a view of. In no event should the author or Transparently Pte Ltd be liable for any direct or indirect trading losses caused by any information contained in these views. All expressions of opinion are subject to change without notice, and we do not undertake to update or supplement this report or any of the information contained herein. Mark Jolley Mark has been an investment strategist for almost 40 years and has advised some of the world’s biggest investment funds, public companies and notable investors. In the mid-1990s, as a global investment strategist with Deutsche Bank, Mark produced a daily note read by more than 16,000 investment professionals including voting members of the Federal Reserve and the European Central Bank. In the 2000s, Mark worked as Deutsche Bank’s Asian strategist and then as strategist for China Construction Bank. He is now an independent analyst. AI in accounting Accounting fraud Analysis Case study Pharmaceuticals US Featured Insights Think Transparently Explore our resources to master the power of AI in financial analysis. Explore all Analysis and Opinion The Short Sellers Digest: Carvana, NexGen Energy, Ubiquity Track short-seller targets and executive exits with Transparently’s forensic signals and accounting quality risk ratings. Updated weekly for investors. Mark Jolley February 10, 2026 Analysis and Opinion What’s broken in auditing? What's wrong with auditing? This piece explores how inherent conflicts, flawed 'reasonable assurance' standards and industry lobbying undermine investor trust and audit quality. Germaine Chia January 16, 2026 Explainers How we do AI: The basics Learn the basics of Transparently.ai's cutting-edge AI. Our system uses pattern recognition and vast data to detect potential accounting fraud with unmatched speed and consistency. Mark Jolley December 4, 2025 Analysis and Opinion NIO: What our accounting risk system found before GIC’s lawsuit Transparently’s AI-powered system flagged key accounting risks at NIO years before GIC’s fraud lawsuit, highlighting the predictive power of accounting risk models. Mark Jolley October 21, 2025

.. copy and pasted from the following website.. from the website called "U.S. Securities and Exchange Commision" .. .. .. Nighingale Mist the second: "oh" .. .. .. .. .. https://www.sec.gov/enforcement-litigation/distributions-harmed-investors/matters-valeant-pharmaceuticals-international-inc-nka-bausch-health-companies-inc-j-michael-pearson

Harmed Investor In the Matters of Valeant Pharmaceuticals International, Inc. n/k/a Bausch Health Companies Inc., J. Michael Pearson, Howard B. Schiller, and Tanya R. Carro, CPA Admin. Proc. File Nos. 3-19899, 3-19900, 3-19901, 3-19902 On July 31, 2020, the Commission issued four separate but related Orders instituting and simultaneously settling administrative proceedings (the “Orders”) against Valeant Pharmaceuticals International, Inc., n/k/a Bausch Health Companies Inc., J. Michael Pearson, Howard B. Schiller, and Tanya R. Carro, CPA (collectively, the “Respondents”). In the Orders, the Commission found that beginning in 2014, when announcing certain GAAP and non-GAAP financial measures, Valeant among other things, misstated revenue transactions and included erroneous revenue allocations. For example, the Orders found that, for five consecutive quarters, the Respondents touted double-digit same store organic growth, a non-GAAP financial measure that represented growth rates for businesses owned for one year or more. Much of that growth came from sales to Philidor, a mail order pharmacy Valeant helped establish, fund, and subsidize. The Orders found that Valeant improperly recognized revenue relating to Philidor sales and did not disclose its unique relationship with or risks related to Philidor in its SEC filings and earnings and investor presentations. Valeant ended its ties to Philidor in October 2015 and restated its 2014 financial statements in April 2016, reducing the revenue that was improperly recognized. The Orders also found that Valeant failed to disclose the material impact of certain revenue it received from drug wholesalers following a 500% increase of the price of a single drug that Valeant acquired in April 2015. Valeant erroneously attributed the resulting revenue to more than 100 unrelated products and did not record any as attributable to that drug. Additionally, in its SEC filings and earnings presentations for the second and third quarters of 2015 and its 2015 year-end report, Valeant failed to disclose the impact of that allocation on its GAAP and non-GAAP financial measures. The Commission ordered Respondents to pay civil penalties for a collective total $45,425,000. In each of the Orders, the Commission also created a Fair Fund, pursuant to Section 308(a) of the Sarbanes-Oxley Act of 2002, so the penalties collected can be distributed to harmed investors. See the Commission’s Orders: Release Nos. 33-10809, 33-10810, 33-10811, 33-10812. On January 8, 2024, the Commission issued an Order consolidating the Fair Funds in each of the Orders for purposes of distribution administration. See the Commission’s Order: Release No. 34-99284. On February 5, 2024, the Commission issued an Order appointing Miller Kaplan Arase LLP as the Tax Administrator of the Fair Fund. See the Commission’s Order: Release No. 34-99468. On February 12, 2024 the Commission issued an Order appointing KCC Class Action Services, LLC as the Fund Administrator to oversee the administration and distribution of the Fair Fund and set the administrator’s bond amount. See the Commission’s Order: Release No. 34-99516. On June 24, 2024 the Commission published a notice of the proposed plan of distribution and opportunity for comment and simultaneously published the proposed plan of distribution (“Proposed Plan”). The notice provides the public with 30 days to submit their comments on the Proposed Plan. See the Commission’s Notice: Release No. 34-100410 and the Proposed Plan. The Proposed Plan provides that the distribution of the Fair Fund shall be made to those injured investors who were harmed by the Respondents’ conduct described in the Orders, in connection with improper revenue recognition and materially misleading disclosures as calculated by the methodology used in the Plan of Allocation in the Plan. On August 22, 2024, the Commission issued an order approving the plan of distribution and published the approved plan of distribution (“Plan”) See the Commission’s Order: Release No. 34-100808 and the Plan

.. copy and pasted from the following website .. .. Nightingale Mist the second: ..."... sooo.. Darren Entwistle it is.." .. .. .. .. https://www.telus.com/en/about/leadership-team/darren-entwistle

Darren Entwistle President and CEO Darren on LinkedIn Darren on Instagram Darren Entwistle joined TELUS in 2000 as President and CEO, and is the longest-serving CEO in the global telecommunications industry. Under Darren’s leadership, TELUS has evolved from a regional telephone company serving Western Canada into a global communications and information technology leader. Since 2000, TELUS has generated a total shareholder return of 611 per cent. This result is 15 percentage points higher than the TSX’s return of 596 per cent and 552 percentage points higher than the return from the MSCI World Telecom Services Index of 59 per cent. In addition, throughout the past 25 years, TELUS’ enterprise value has more than quintupled to $57.4 billion and EBITDA has more than doubled to $7.4 billion. During this same timeframe, the TELUS brand has increased in value from a few hundred million dollars to $12.1 billion today, ranked as the most valuable telco brand in Canada and the 15th most valuable telco brand, globally, by Brand Finance; the most reputable telco brand in 2025 by Leger; the most trusted telco brand and one of Canada’s Most Authentic Brands by the Gustavson School of Business in 2023; and as the 2021 Brand of the Year by Strategy Magazine. Darren believes passionately that TELUS’ greatest asset is the more than 130,000 team members and retirees around the globe who comprise the TELUS family. In this regard, TELUS is consistently recognized for its global leadership in respect of team engagement and has been ranked number one in the world for a company of its size and composition according to third-party surveyor Mercer. This incredible level of engagement led to TELUS being the first organization ever to be inducted into the Best of the BEST Hall of Fame by the Association for Talent Development in acknowledgement of its global excellence in learning and development. Moreover, TELUS was named one of Canada’s Top 10 Most Admired Corporate Cultures by Waterstone Human Capital for three consecutive three-year award timeframes, and earned the distinction of being the sixth company ever inducted into Canada’s Most Admired Corporate Cultures Hall of Fame. In addition, TELUS has been recognized by Forbes as one of the World’s Best Employers four times, and, notably, was the only Canadian/U.S. telecommunications company on the list in 2024. The world-leading culture within TELUS empowers team members to deliver on the top corporate priority of providing the best client experience in the industry as measured by customers’ likelihood to recommend TELUS products and services. The team’s efforts have been lauded by consumers who ranked Koodo the highest of all Canadian wireless carriers for three years in the J.D. Power Wireless Customer Care Satisfaction survey and also gave TELUS top marks in the Canadian Wireless Network Quality Study. This commitment to putting customers first underscores the TELUS team’s long-standing dedication to providing Canadians with the network speed, reliability and coverage to help them live better lives and remain connected to what matters most. As a result, TELUS is consistently recognized for global leadership in broadband network excellence from independent, third-party organizations, including UK-based Opensignal as well as U.S.-based Ookla, J.D. Power and PCMag. At the heart of TELUS’ culture is a deeply rooted belief in the symbiotic relationship between business success and the welfare of our communities. Since 2000, TELUS and its team members have generously devoted $1.8 billion in value, including 2.5 million days of volunteerism in local communities, helping millions of citizens in need. This heartfelt commitment was recognized in 2010 when TELUS became the first Canadian company to be named the Most Outstanding Philanthropic Corporation globally by the Association of Fundraising Professionals. In 2012, the team’s passion for giving back was honoured once again with an inaugural Prime Minister’s Volunteer Award; in 2018, TELUS earned the Business as a Force for Good Award in the category of Corporate Social Responsibility from the INSEAD National Alumni Association of Canada; and in 2020, the Wall Street Journal ranked TELUS 29th in their 100 Most Sustainably Managed Companies in the World report, and 15th, globally, in the subcategory of social capitalism – TELUS was the only telecommunications company and one of only three Canadian companies named to the list. Moreover, reflecting TELUS’ leadership in responsible corporate citizenship, the company’s sustainability practices continue to earn consistent global recognition. Notably, TELUS has been named to the Dow Jones Sustainability North America Index for 24 consecutive years – a feat unequalled by any of its North American peers – and has also been named to the World Index 14 times. In addition, TELUS earned the inaugural Terra Carta Seal, presented by His Royal Highness the Prince of Wales to global corporations that are demonstrating their commitment to the creation of genuinely sustainable markets, and was recognized in TIME Magazine's inaugural World's Most Sustainable Companies 2024, ranking #21 of 500 companies globally, #2 Canadian company and #1 Canadian telecommunications company. In 2025, TELUS was again named to this prestigious list, ranking as the top North American telco. In recognition of Darren’s exemplary contributions to the community and to Canada as a whole, in 2018, he was appointed to the Order of Canada. Similarly, in 2003 he was awarded the Queen Elizabeth II Golden Jubilee Medal and in 2012 he received the Queen Elizabeth II Diamond Jubilee Medal. In 2022, Darren was inducted into the Business Laureates of British Columbia Hall of Fame; was named Canadian Business Leader of the Year by the Canadian Chamber of Commerce; and was awarded the International Horatio Alger Award by the Horatio Alger Association of Distinguished Americans, an honour bestowed upon North America’s most respected leaders in appreciation of their hard work and, perseverance and ability to overcome obstacles. Additionally, Darren earned recognition as CEO Achiever, Champion of the Year by CEO World Awards, was named the Most Admired CEO by Waterstone Human Capital in 2017, received the President’s Award from the Institute for Performance and Development in 2015, and was presented with the inaugural Innovator of the Year award from the Ontario Science Centre in 2012 in honour of his contributions to innovation in science. Darren is also the recipient of the 2011 Canadian Business Leader of the Year Award from the University of Alberta; the 2011 Champion of Public Education Award from The Learning Partnership; and the 2011 T. Patrick Boyle Founders Award by the Fraser Institute for outstanding leadership in business and philanthropy. On a worldwide basis, Darren was recognized with the CEO Leadership in Action Award from Diversity Journal in 2011 and the National Philanthropy Business Leader of the Year Award in 2010 from the David Foster Foundation. Darren has a Bachelor of Economics (Honours) degree from Concordia University, an MBA in Finance from McGill University and a diploma in Network Engineering from the University of Toronto. He has received honorary Doctorates of Law from McGill University, Concordia University, the University of Alberta and the University of Victoria. Darren also holds an honorary Bachelor in Business Administration from the Northern Alberta Institute of Technology and is an Honorary Fellow of The Royal Conservatory in Toronto. Reflecting Darren’s belief that diversity creates a whole that is far greater than the sum of its parts, TELUS is a signatory of the Catalyst Accord mandating an increase in the overall proportion of Canadian Financial Post 500 board seats held by women. In 2020, TELUS also signed the Pledge, created through the BlackNorth Initiative, committing to help end anti-Black systemic racism. Darren is a founding member of The 30% Club in Canada, a founding member of the Canadian Board Diversity Council and a vocal proponent of their Diversity 50 initiative, as well as a signatory of both the Ontario Securities Commission’s Staff Consultation Paper regarding Women on Boards, and the B.C. Minerva Pledge. Darren’s past directorships include: George Weston Ltd., the Business Council of Canada, TD Bank Financial Group, McGill University Board of Governors and Bell Cablemedia Plc in the United Kingdom. Support Find a store Contact us The TELUS team acknowledges that our work spans many Territories and Treaty areas and we are grateful for the traditional Knowledge Keepers and Elders who are with us today, those who have gone before us and the youth that inspire us. We recognize the land and the benefits it provides all of us, as an act of reconciliation, as recommended by the Truth and Reconciliation Commission’s (TRC) 94 Calls to Action and express gratitude to those whose territory we reside on, work on or are visiting. Learn more about TELUS’ commitment to Reconciliation.

.. track three.. of disc four.. track three.. of disc four.. track three.. of disc four.. of the four CD set titled "simply soundtracks" .. a BMG company.. two thousand and seventeen .. Union Square Music Ltd .. .. .. .. track three.. of disc four.. is the official, quintessential, diva music of.. Pre crisis Blond Haired Lana Lang, played by Embeth Davditz: ..".. OH.. Mr. Edge.. your first name.. I found it.. He's Dan Morgan.. the great Dan Morgan.. He wrote a monumental work titled 'Merchants of Grain'.." .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult.. stochastic disturbance terms.. three dollars..

.. Nightingale Mist the second: ..".. Whoaa.. what does THIS mean? .. This article is copy and pasted from the website titled 'Moneycontrol'.. This article is written by Moneycontrol News.."..

Sponsored Moneycontrol 901.6K Followers AI’s next biological leap could be cracking the genome, says Google DeepMind scientist Story by Moneycontrol News • 1w • 2 min read AI’s next biological leap could be cracking the genome, says Google DeepMind scientist AI’s next biological leap could be cracking the genome, says Google DeepMind scientist © Moneycontrol AI’s next big biological frontier is not just mapping proteins but understanding the deeper “recipe book of life” hidden inside human DNA, Google DeepMind’s Vice President of Research Pushmeet Kohli said in an interview with Moneycontrol's Managing Editor, Dr Nalin Mehta. Kohli, whose teams helped build the Nobel Prize-winning AlphaFold model that predicts protein structures, said the next grand scientific challenge for artificial intelligence is deciphering the human genome and interpreting what genetic codes actually mean for diseases, development and treatment. A Quiet Shift Is Forming Across Canada A Quiet Shift Is Forming Across Canada seniorprimeca.com · Sponsored call to action icon more “If proteins are the building blocks and ingredients of life, the key question now is to decipher the recipe book of life, our genome,” Kohli said. He explained that while scientists have successfully developed technologies to read DNA sequences over the past few decades, understanding their full implications remains incomplete. According to Kohli, the genome holds crucial information about how humans develop, which diseases they may be susceptible to, and how medical interventions could be tailored. “We are yet to really decipher it and understand the meaning of the genome,” he noted, describing it as one of the biggest scientific challenges currently underway in AI research. He added that the long-term goal is to understand the effect of every possible change in the genetic code and use that knowledge not only for diagnosing diseases but also for developing more precise treatments. Related video: What will humans actually look like in 100 years (TED) TED What will humans actually look like in 100 years Current Time 0:01 / Duration 15:45 0 View on Watch View on Watch Kohli also said AI’s growing role in biology is already demonstrating how technology can level the global scientific playing field. Citing AlphaFold as an example, he noted that determining the structure of a single protein earlier took years and millions of dollars in laboratory work. Today, researchers can obtain similar structural insights in seconds through AI databases. This shift, he said, is helping democratise science by giving smaller research institutions and scientists in developing countries access to tools that were once limited to well-funded laboratories. “All of that millions of dollars and multiple years has been transformed into one click,” Kohli said, adding that such acceleration shows how AI can expand scientific opportunity across borders. Sponsored Moneycontrol Visit Moneycontrol ChrysCapital in final stage talks to acquire parent Novartis AG's stake in Novartis India TVF acquires rights to adapt Emmy-winning medical drama The Pitt AI can do many things, but can't...: Rishi Sunak quips on Delhi traffic at AI summit Sponsored

.. Nightingale Mist the second: ..".. Can February the eighteenth be my birthday.. I wonder.. who was my mother.. who was the woman who gave birth to me.. and then.. February the nineteenth is my first day of life after I was born on February the eighteenth.." .. hyacinth fyenshya Winona Horowitz Ryder Fyenshya el eleven year old kal el everest raudsepp johnson the woman who gave birth to him is Laine Raudsepp Morningstar. Artemis. Eve. Aphrodite. Freia or Freya. Ishtar.

.. Nightingale Mist the second: "what?" .. copy and pasted from the website called the "Daily Mail" .. article written by Adam Pogrund .. today is the date of February the nineteenth, in the year two thousand and twenty six..

Daily Mail 2M Followers Germany's army chief warns Europe will suffer 'things we cannot even imagine right now' Story by Adam Pogrund • 12h • 5 min read Vladimir Putin will cause Europe to suffer 'things we cannot even imagine right now', a German army chief has warned. Major General Wolf-Jürgen Stahl, president of the Federal Academy for Security Policy, claimed Germany was already under attack by Russia but expects it to wage a much stronger war of aggression against Nato in Europe. Meet 11 of the hottest Olympians at the 2026 Winter Games in Milano-Cortina Meet 11 of the hottest Olympians at the 2026 Winter Games in Milano-Cortina Postmedia · Sponsored call to action icon more He also lashed out at Donald Trump for being an 'egomaniac, narcissistic, erratic dealmaker with authoritarian leanings'. Speaking at the German-British Society, he said: 'When I see how Putin has acted up to now, and the way that he is in my assessment on a mission against the West, then there is no question of whether he will use military means. If he gets the opportunity, he will use them.' He expressed concern at how European leaders would react if Russia were to invade Nato territory and said the country's liberal democratic order is under threat. He said: 'People will immediately say "Er, we don’t need to fight at all. We have to resolve it diplomatically. We can’t resolve it militarily". 'I don’t know what discussions, what currents might be unleashed here in Germany. I do have a certain concern about that.' He added: 'If Nato territory is occupied by Russian soldiers, then Nato has to say: "How do we chuck them out so that the territory is restored to Nato, not just de jure but de facto?”' Europe will suffer 'things we cannot even imagine right now', a German army chief has warned Europe will suffer 'things we cannot even imagine right now', a German army chief has warned The army chief claimed Germany was already under attack by Russia but expects it to wage a much stronger war of aggression against Nato in Europe The army chief claimed Germany was already under attack by Russia but expects it to wage a much stronger war of aggression against Nato in Europe 'The world is coming apart at the seams. It’s turbulent. It’s rough. It’s lawless, it’s in a state of disorder… we urgently need to work on shoring up our foundations.' The defence chief hit out at Trump but said he was still confident the US would provide its 'nuclear umbrella' to Europe, even if some of its ground forces were removed from the continent. The CPAP Store - Lowest Priced CPAP Products - CPAP Supplies Canada The CPAP Store - Lowest Priced CPAP Products - CPAP Supplies Canada thecpapstore.ca · Sponsored call to action icon more He said: 'My biggest intellectual challenge is the president. 'I saw at the [Munich] security conference that I’m not the only one who has difficulties here; the Americans do too. They have an erratic president. 'And so it’s hard for me whenever they all say, "No, we’re staying in Europe, a stable Europe is a vital interest for us and we need it for our own security", and then they experience a president like this.' Stahl claimed the key four pillas of German security, the EU, Nato, national economic strength and social cohesion, are under significant pressure. Russian aggression is forcing European nations to consider nuclear weapons to guard against attacks. Poland's president Karol Nawrocki said the country should start developing nuclear weapons of its own He said he was a 'great supporter of Poland joining the nuclear project', which he wants to underpin the country’s security strategy. Major General Wolf-Jürgen Stahl, president of Germany's Federal Academy for Security Policy, also lashed out at Donald Trump for being an 'egomaniac' Major General Wolf-Jürgen Stahl, president of Germany's Federal Academy for Security Policy, also lashed out at Donald Trump for being an 'egomaniac' He expressed concern at how European leaders would react if Russia were to invade Nato territory (Pictured: Ukrainian artillery troops) He expressed concern at how European leaders would react if Russia were to invade Nato territory (Pictured: Ukrainian artillery troops) 'This path, with respect for all international regulations, is the path we should take. 'We must work towards this goal so that we can begin the work. We are a country right on the border of an armed conflict. The aggressive, imperial attitude of Russia towards Poland is well known.' CPAP Hose CPAP Tubing 6 Foot Long Standard Or Slimline Black Or Grey, Standard / Grey CPAP Hose CPAP Tubing 6 Foot Long Standard Or Slimline Black Or Grey, Standard / Grey CPAPfix · Sponsored call to action icon more And German chancellor Friedrich Merz said while Germany would not develop its own nuclear deterrent, it could 'theoretically' carry British or French warheads. Stahl said: 'It’s scarcely conceivable, how the Poles are suddenly discussing getting their own nuclear deterrent. That’s not in the Americans’ interests.' His comments come as Russia continues to press on with its invasion of Ukraine after US-mediated peace talks collapsed in less than two hours. Volodymyr Zelensky claimed it was unfair that Donald Trump was placing more pressure on his country than on Russia. The second day of talks concluded on Wednesday, though neither side signalled they were any closer to ending Europe's deadliest conflict since World War II. The talks wrapped up after just two hours, much shorter than the six hours of meetings on Tuesday, according to the head of Russia's delegation. Neither side elaborated on what they discussed or whether they had agreed on anything, but both signalled the discussions had been tricky. Trump put pressure on Ukraine on Monday to make a deal, saying they 'better come to the table, fast'. US-mediated peace talks on Ukraine took place in Geneva but collapsed after just two hours US-mediated peace talks on Ukraine took place in Geneva but collapsed after just two hours The United States has been pushing for an end to the nearly four-year war, but has so far failed to broker a compromise between Moscow and Kyiv The United States has been pushing for an end to the nearly four-year war, but has so far failed to broker a compromise between Moscow and Kyiv But Zelensky told Axios on Tuesday it was 'not fair' that Ukraine - and not Russia - was facing more pressure, adding that lasting peace would not be achieved if 'victory' was just handed to Moscow. 'I hope it is just his tactics and not the decision,' Zelensky said. The Ukrainian leader said late Tuesday he was ready to move 'quickly' towards a deal but questioned whether Russia was serious about peace. The US has been pushing for an end to the nearly four-year war, but has so far failed to broker a compromise between Moscow and Kyiv on the key issue of territory. The latest talks on Wednesday were 'difficult, but business-like,' the head of Russia's delegation Vladimir Medinsky told Russian state media after the talks. While the talks were still ongoing, Zelensky accused Russia of seeking to 'drag out' negotiations and said the first day had been 'difficult'. Russia is pushing for full control of Ukraine's eastern Donetsk region as part of any deal, and has threatened to take it by force if Kyiv does not cave at the negotiating table. But Ukraine has rejected this demand, which is politically and militarily fraught, and signalled it will not sign a deal without security guarantees that deter Russia from invading again. Russia launched its full-scale invasion of Ukraine in February 2022. Servicemen from the strike drone platoon at an undisclosed location in the Donetsk region, eastern Ukraine Servicemen from the strike drone platoon at an undisclosed location in the Donetsk region, eastern Ukraine A damaged building after a Russian drone hits residential areas in Sumy, northeastern Ukraine, on February 17, 2026 A damaged building after a Russian drone hits residential areas in Sumy, northeastern Ukraine, on February 17, 2026 The ensuing conflict has resulted in a tidal wave of destruction that has left entire cities in ruins, tens of thousands of soldiers and civilians dead and forced millions of people to flee their homes. Hours before talks began, Russia fired 126 attack drones and a ballistic missile at Ukraine, according to the Ukrainian air force. Russian drone and artillery attacks overnight and late Tuesday wounded at least one person and caused damage to buildings, according to Ukrainian regional authorities. Russia occupies around one-fifth of Ukraine - including the Crimean peninsula it seized in 2014 - and areas that Moscow-backed separatists had taken prior to the 2022 invasion. Ukraine says handing Russia more territory will effectively 'reward' Russia for invading and embolden it to attack again. Russia has been slowly seizing territory across the sprawling front line for months, claiming control of villages in the southern Zaporizhzhia region and northern Sumy region on Wednesday. But its wartime economic worries are mounting, with growth stagnating and a ballooning budget deficit as sanction-hit oil revenues drop to a five-year low. Read more Sponsored Daily Mail Visit Daily Mail The four easy habits that could prevent dementia more than exercise Revealed: Anthony Joshua's planned return to the ring after death of two close friends in car crash Step back into the Roman Empire Sponsored

.. Nightingale Mist the second: ..".. Okay how about this.. When Margaret Qualley plays Violette le duc and Robert Pattinson plays Gabriel.. then Winona Ryder will play a truly adorable, lovable, sacred, truly holy spirit angelic role.. that is.. Winona Ryder will play.. this lovable, angelic role is the role of Isabelle.. or Isabella.. I.. I can't remember.. I think her name is Isabelle.. and she is the delicate as May Welland.. delicate as Maggie Verver.. female lover of Violette le duc.. She is Isabelle.. or Isabella.. and WInona Ryder should play this adorable, truly beloved to God role.. the role of Isabelle.. or Isabella.. when Margaret Qualley plays her lover, Violette le duc.."..

.. Nightingale Mist the second, played by Winona Horowitz Emmanuelle Hyacinth Ryder: ..".. Who is this stunningly genius level intellect young handsome man.. He is the true, authentic genius, Davy Kirkpatrick.. and this article is copy and pasted from the website for the 'Daily Galaxy'.. and this article is written by Arezki Amiri.."..

Sponsored Daily Galaxy 64.2K Followers “I mapped the invisible”: American high-school student stuns astronomers by discovering 1.5 million hidden cosmic objects Story by Arezki Amiri • 8h • 4 min read From Classroom To Cosmos A Teen Mapped 1.5 Million Hidden Space Objects. Credit: Fox 11 Los Angeles | The Daily Galaxy --Great Discoveries Channel From Classroom To Cosmos A Teen Mapped 1.5 Million Hidden Space Objects. Credit: Fox 11 Los Angeles | The Daily Galaxy --Great Discoveries Channel © Daily Galaxy CA The numbers arrived with the dispassion of a telemetry readout: 10.5 years of observations, 200 billion individual detections, a complete infrared survey of the entire sky. For more than a decade after the NEOWISE telescope began its reactivated mission, the data sat in institutional archives, processed for its primary purpose of asteroid tracking but otherwise unread. The variable objects, quasars that flickered, stars that pulsed, binaries that dimmed as they eclipsed, remained invisible, buried in the noise of their own abundance. If You Receive CPP In Ontario, You Should See This If You Receive CPP In Ontario, You Should See This Canadian Final Expense · Sponsored call to action icon more A Caltech senior research scientist named Davy Kirkpatrick had spent years looking at that dataset and wondering what it contained. He had mentored high school students for five summers, but he also wanted to extract something from the NEOWISE archive that no one had yet extracted: a complete catalog of every infrared source that changed brightness over time. This mosaic is composed of images covering the entire sky, taken by the Wide-field Infrared Survey Explorer (WISE) This mosaic is composed of images covering the entire sky, taken by the Wide-field Infrared Survey Explorer (WISE) © Daily Galaxy CA The problem, as he later put it, was that the data had grown too large for conventional methods. “At that point, we were creeping up towards 200 billion rows in the table of every single detection that we had made over the course of over a decade,” Kirkpatrick said. His idea for a summer project was modest: take a small patch of sky, find some variable stars by hand, and publish them as a proof of concept. Then a 17-year-old from Pasadena High School walked into his laboratory and proposed doing something else entirely. Related video: Not an asteroid, not a comet - this object didn’t look like anything we know (TED) TED Not an asteroid, not a comet - this object didn’t look like anything we know Current Time 0:00 / Duration 13:24 0 View on Watch View on Watch The Model That Runs at 53 Microseconds Per Star Matteo Paz had attended Caltech’s public stargazing lectures with his mother since elementary school. By the summer of 2023, when he joined Kirkpatrick’s lab through the university’s Summer Research Connection program, he had completed AP Calculus in eighth grade through Pasadena Unified’s accelerated Math Academy and was studying undergraduate level mathematics. An elective course integrating coding and theoretical computer science had introduced him to machine learning. The Caltech feature on exploring space with AI traces the origins of their collaboration through these outreach programs. Paz told Kirkpatrick on their first day that he wanted to publish a paper. Kirkpatrick did not discourage him. “He has allowed an unbridled learning experience,” Paz said. “I think that’s why I’ve grown so much as a scientist.” The model Paz developed, named VARnet, processes astronomical time series data through three integrated stages. Wavelet decomposition reduces the impact of spurious measurements. A modified discrete Fourier transform extracts periodic features from irregularly sampled light curves. The Anomaly Extraction Pipeline The Anomaly Extraction Pipeline © Daily Galaxy CA The Astronomical Journal published the complete technical specifications, available in the peer reviewed paper on the VARnet architecture, describing how convolutional neural networks classify each source into one of four categories: non variable, transient events such as supernovae, intrinsic pulsators, or eclipsing binary systems. Meet 11 of the hottest Olympians at the 2026 Winter Games in Milano-Cortina Meet 11 of the hottest Olympians at the 2026 Winter Games in Milano-Cortina Postmedia · Sponsored call to action icon more The performance metrics show processing times of less than 53 microseconds per source on a GPU with 22 gigabytes of VRAM, with an F1 score of 0.91 on a validation set of known variable objects. The model scales to the full NEOWISE dataset. A Mentorship Forged in Tennessee Kirkpatrick grew up in a farming community in Tennessee. His ninth grade chemistry and physics teacher, Marilyn Morrison, told him and his mother that he had scientific potential and outlined the courses he would need for college. She was, Kirkpatrick said, the reason he became an astronomer. His professional background is detailed on his staff page at IPAC, the Infrared Processing and Analysis Center at Caltech where the NEOWISE data is archived. “I wanted to pass on that same sort of mentoring to someone else and hopefully many someone eleses,” Kirkpatrick said. “If I see their potential, I want to make sure that they are reaching it. I’ll do whatever I can to help them out.” Matteo Paz With Caltech President Thomas F. Rosenbaum Matteo Paz With Caltech President Thomas F. Rosenbaum © Daily Galaxy CA That philosophy shaped the summer project’s direction. When Paz proposed building anAI model to analyze the entire NEOWISE database rather than a single patch of sky, Kirkpatrick connected him with Caltech researchers Shoubaneh Hemmati, Daniel Masters, Ashish Mahabal, and Matthew Graham, who provided expertise in machine learning techniques for astronomy and in the analysis of objects that vary on different timescales. The CPAP Store - Lowest Priced CPAP Products - CPAP Supplies Canada The CPAP Store - Lowest Priced CPAP Products - CPAP Supplies Canada thecpapstore.ca · Sponsored call to action icon more The collaboration revealed a constraint in the NEOWISE data. The telescope’s observational rhythm, scanning in great circles centered on the Sun, meant it could not systematically detect objects that flashed once and faded, or those that changed gradually over years. Some classes of variable phenomena would remain invisible to any automated survey based on NEOWISE data alone. The 1.5 Million Candidates VARnet flagged 1.5 million potential variable objects in the NEOWISE archive. The figure does not represent 1.5 million confirmed discoveries in the traditional sense. Each flagged source is a candidate requiring follow up observation and classification by astronomers. Some will prove to be known objects now characterized in infrared wavelengths for the first time. Some will be false positives. Some fraction will be genuinely new detections of quasars, variable stars, and transient events. The full catalog is scheduled for publication in 2025. When released, it will provide the astronomical community with a dataset large enough to support statistical studies of infrared variability across the entire sky, rather than the piecemeal analyses that have characterized the field to date. This illustration shows the Wide-field Infrared Survey Explorer (WISE) spacecraft in Earth orbit. This illustration shows the Wide-field Infrared Survey Explorer (WISE) spacecraft in Earth orbit. © Daily Galaxy CA Paz, now a Caltech employee working at IPAC while finishing high school, described the model’s potential applications beyond astronomy. “The model I implemented can be used for other time domain studies in astronomy, and potentially anything else that comes in a temporal format,” he said. “I could see some relevance to chart analysis, where the information similarly comes in a time series and periodic components can be critical. You could also study atmospheric effects such as pollution, where the periodic seasons and day night cycles play huge roles.” Enjoyed this article? Subscribe to our free newsletter for engaging stories, exclusive content, and the latest news. Sponsored Daily Galaxy Visit Daily Galaxy “It keeps me up at night”: NASA warns Earth is threatened by 15,000 asteroids big enough to wipe out a city SpaceX’s Falcon 9 rocket creates stunning plume over Florida, capturing the power of space travel Fossils found at 8,000 meters on Everest reveal an ancient ocean beneath the Himalayas Sponsored

.. track thirteen circe angelheart.. of disc one.. track thirteen circe angelheart.. of disc one.. track thirteen circe angelheart.. of disc one.. track thirteen.. of disc one.. of the achingly haunting score composed by John Williams for the very first Star Wars movie ever made.. namely, "Star Wars: Episode Four: a New Hope".. track thirteen.. of disc one.. track thirteen.. of disc one.. is the official, quintessential music of... this Sean Bean Darkseid Winona Ryder Lady Styx scale echelon planet apocalips realm reality.. Demi Moore plays the angelic, sacred woman who gives birth to Lady Palpitine, who is played by Winona Ryder.. that means.. Demi Moore plays the beloved wife of Ian McDiarmid's Senator Palpitine.. He is the biological father of Lady Palpitine, played by Winona Ryder .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult winona horowitz emmanuelle hyacinth "Lady Palpitine" ryder demi "Elizabeth Sparkle" moore margaret "nude sue" qualley demi "Medusa Palpitine, biological mother of Lady Palpitine aka Winona Ryder lady palpitine" moore angelina "Ramza Sin Jei in the Star Wars Sequels" jolie daisy "padmethenna rei" ridley.. stochastic disturbance terms.. three dollars..

.. Nightingale Mist the second, played by Winona Horowitz Emmanuelle Hyacinth Ryder: ..".. Who is this fascinating, handsome, charismatic man.. He is Clifford Stone.. He is the truly, authentically remarkable Clifford Stone.. and I love him.. I am Nightingale mist the second and I love Clifford Stone.. This article from the internet website of the 'Daily Mail'.. article written by Rob Waugh.. describes the fascination and the enchantment of the wonderful Clifford Stone.."..

Daily Mail 2M Followers I communicated with non-human intelligence... and what they told me proves God's existence Story by Rob Waugh • 5d • 4 min read A resurfaced military interview presents extraordinary claims about extraterrestrial intelligence, the scientific confirmation of a single creator, and technology that may blur the boundary between life and death. The account came from Clifford Stone, a longtime US Army sergeant who, over the course of his life, alleged direct involvement in classified encounters with non-human intelligence during his military service. If You Receive CPP In Ontario, You Should See This If You Receive CPP In Ontario, You Should See This Canadian Final Expense · Sponsored call to action icon more Until his death in 2021, Stone consistently maintained that his claims were rooted in firsthand encounters rather than speculation, describing them as experiences that had permanently changed his understanding of religion, mortality, and humanity's place in the universe. According to Stone, some of those encounters involved telepathic communication with an extraterrestrial entity he described as calm, curious and technologically advanced. He said the being, which he called 'Korona,' expressed interest in human belief systems and conveyed information that, if true, would upend long-standing debates about the relationship between science and faith. Stone claimed that Korona's civilization had reached what it considered a scientific conclusion about the existence of a creator, not as a matter of belief, but as an empirically established reality. Related video: This Is How Science Could Finally Prove Aliens Exist (TED) TED This Is How Science Could Finally Prove Aliens Exist Current Time 0:00 / Duration 18:06 0 View on Watch View on Watch Scholars of religion and philosophy have long debated whether scientific inquiry can ever address metaphysical questions such as the existence of God. Stone claimed that belief in a singular creator is 'no longer a faith-based ideal,' and argued that science from advanced intelligence now supports the existence of what many people call God. The account came from Clifford Stone (pictured), a longtime US Army sergeant who, over the course of his life, alleged direct involvement in classified encounters with non-human intelligence during his military service The account came from Clifford Stone (pictured), a longtime US Army sergeant who, over the course of his life, alleged direct involvement in classified encounters with non-human intelligence during his military service Stone further alleged that this same intelligence possessed technology capable of facilitating communication between the living and the dead, though he stressed that such interactions were tightly constrained. 'They even have the means to communicate with their loved ones. It's not some parlour trick,' he claimed. 'They really have the means to do it. But there are forbidden questions that you can't ask about what happens after death.' A Quiet Shift Is Forming Across Canada A Quiet Shift Is Forming Across Canada seniorprimeca.com · Sponsored call to action icon more That restriction, Stone claimed, was not presented as a technical limitation but as an enforced boundary, one that prevented deeper inquiry into the nature of death itself. He suggested that certain knowledge may either be dangerous, destabilizing or simply inaccessible to human understanding at this stage of development. Beyond theology and mortality, Stone made one of his most controversial assertions. He claimed that non-human beings are not distant visitors, but active observers already present on Earth. He claimed they move quietly among humans, studying behavior, emotion and belief in an effort to better understand the species. Stone did not explain how such beings might conceal themselves, nor did he provide physical evidence to support the claim. He framed the idea instead as a long-term observational effort, similar to anthropological fieldwork conducted by a more advanced civilization. According to Stone, some of those encounters involved telepathic communication with an extraterrestrial entity he described as calm, curious and technologically advanced According to Stone, some of those encounters involved telepathic communication with an extraterrestrial entity he described as calm, curious and technologically advanced Born on January 2, 1949, in Portsmouth, Ohio, Stone joined the US Army in 1969. His official military records list his primary role as an administrative and legal specialist, a position he held while serving for more than two decades. Over time, however, Stone asserted that his duties extended far beyond clerical work. The Best Star Trek Game The Best Star Trek Game Star Trek Fleet Command · Sponsored call to action icon more He claimed he was quietly reassigned to classified recovery operations involving unidentified craft and, in some cases, non-human biological entities - these assertions have never been independently verified. The Department of Defense has never confirmed Stone's involvement in any program related to extraterrestrial recovery or communication, and no declassified documents substantiate his account. Critics have long pointed out this absence of evidence, noting that extraordinary claims demand extraordinary proof. Still, Stone remained steadfast throughout the interview, presenting his experiences as factual rather than speculative. He frequently cited his military service as a basis for credibility and insisted that his silence during active duty was enforced by secrecy protocols rather than lack of evidence. During his lifetime, Stone became a recognizable figure within UFO research circles, where supporters viewed him as an insider willing to speak openly after years of silence. Skeptics, by contrast, argued that his claims relied too heavily on personal testimony and unverifiable experiences. The renewed attention surrounding Stone's interview arrives amid heightened public interest in unidentified aerial phenomena. It follows recent acknowledgments by US government agencies that objects of unknown origin have been tracked performing maneuvers beyond known human technology - though, the government has stopped short of attributing them to extraterrestrial intelligence. That shifting landscape has prompted renewed scrutiny of historical testimonies that were once dismissed outright, including Stone's. For some, his account now appears less fringe; for others, it remains firmly outside the boundaries of evidence-based inquiry. Whether interpreted as testimony, belief or speculation, Stone's claims occupy a volatile space where science, religion and the unknown intersect. His account challenges conventional frameworks by suggesting that humanity's most profound questions - about God, death and existence itself - may already have answers that lie beyond current human comprehension. What remains unresolved is whether those answers exist only in belief, or if they are waiting, as Stone claimed, just beyond the limits of what humanity is allowed to know. Read more Sponsored Daily Mail Visit Daily Mail Vitor Pereira enjoys dream start as he releases Forest stars from shackles to dismantle Fenerbahce Pro-Palestine vandals throw red paint over new branch of Gail's in 'Free Gaza' protest The dossier of allegations from the Epstein files that have led to Andrew's dramatic downfall Sponsored

.. Ghost in the Shell .. inner universe .. is the official, quintessential song of.. hanno alexander ridal raudsepp: ..".. angelina jolie.. angelina jolie.. three year old rahne megan d. iseult .. three year old scarlet witch megan d. iseult.. nine year old megan d. iseult .. forty four year old or forty eight year old or forty nine year old kate moss.. you might know this already.. in a bookstore that was located at the intersection of eglinton and young.. in metropolitan toronto.. I read in the magazine there that Jack Nicholson and.. I think the article said that Jack Nicholson and Batman screenwriter Warren Skaaren.. oh did I spell Warren Skaaren's name accurately.. oh.. that Jack Nicholson and Warren Skaaren both agreed that Jack Nicholson's Joker was Nietzsche.. Nietzsche..".. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult hyacinth ryder monica bellucci angelina jolie.. stochastic disturbance terms.. three dollars..

https://www.youtube.com/watch?v=xIP41E4B-bI&list=RDxIP41E4B-bI&start_radio=1

.. Nightingale mist the second: ..".. heeh eee hee heee.. everybody do the bartman.. hehehehehee..".. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult.. stochastic disturbance terms.. three dollars..

https://www.youtube.com/watch?v=Q7ycjcQHoaw&list=RDQ7ycjcQHoaw&start_radio=1 .. .. in the inwards of the previous URL .. watch?vivien .. Queries Seven yiminy city jesse cisa Questions Hourly ovaltine answer westlake .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult.. stochastic disturbance terms.. three dollars..

.. The Wreck of the Edmund Fitzgerald .. Gordon Lightfoot .. is the official, quintessential song of.. Doctor McPherson of Belleville, Ontario: ..".. hanno.. please.. I'm begging you.. I'm pleading with you.. don't age the pills.. don't oxygenate the clonazepam and escitalopram pills.. in those loose lid plastic cannisters.. please don't.. do that.. please don't.. hanno.. hanno.. hanno.. please don't.. do that.. that might be the source.. doing that.. doing that.. might be the source and cause of this 'mind of poison is' consequence of the clonazepam and escitalopram.. that quote you mentioned from james joyce's finnegans wake.. the quote, 'mind of poison is'.. a very well worded quote by james joyce.. thanks hanno.. thanks hanno.. Today is the date of February the Sixteenth in this year.. the year of two thousand and twenty six.. and these clonazepam and escitalopram pills are from my office in Belleville, Ontario.." .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult.. stochastic disturbance terms.. three dollars..

https://www.youtube.com/watch?v=9vST6hVRj2A&list=RD9vST6hVRj2A&start_radio=1

.. Hanno Raudsepp: ..".. I think my prescription psychiatrist in Belleville, Ontario.. that he's really, really, REALLY struggling to get me medication that will heal my mind.. medication that will bring mental health to my mind.. I think he's fighting through hell's pains to send me medication that will be so helpful for bringing mental health to my mind.. and I really wonder about how.. is there really.. quite a few years ago.. the World Health Organization.. the WHO.. announced a Food Crisis.. I'm trying to remember.. was it an international food crisis.. and I feel like psychotropic medication and food have their origins in the same.. agriculture?... and.. that my wonderful, sacred prescription psychiatrist, Doctor McPherson in Belleville, Ontario.. that he's battling a behemoth to attain mentally healthy medication for me.. and I don't know what that responsibility feels like for him.. to be responsible for someone's mental health.. and.. with pills.. with pills.. and.. there's a finnegans wake quote: 'mind of poison is'... that's what I feel my mind of.. when I was so very fatigued and tired in bed at night the night of yesterday and early early early nighttime hours this morning.. this morning of.. I mean before three o'clock in the morning.. around the midnight hours.. when my mind was the james joyce finnegans wake quote 'mind of poison is'.. I think right now in Trenton, Ontario it is the around fifteen or twenty minutes after five o'clock in the morning.. the nighttime morning of Sunday, February the fifteenth.. this year the year of two thousand and twenty six.." .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult hyacinth "emma frost" ryder monica "zaladane" bellucci kate winslet.. stochastic disturbance terms.. three dollars..

.. the first eleven goddess artemis minutes.. of track five black orchid.. of disc one .. .. .. the first eleven goddess artemis minutes.. of track five black orchid.. of disc one.. of the two CD set "Pink Floyd .. echoes" .. the first eleven goddess artemis minutes.. of track five black orchid.. of disc one.. is the eleven minutes of music which plays.. during the very first meeting of Rogue, played by Savanna Samson and Mystique, played by Holly Madison in "Uncanny X men" Scorcese movie history.. at Mystique's Brotherhood of Evil Mutants outdoor commune on grassy fields.. and then.. after these eleven goddess artemis minutes.. of track five black orchid.. of disc one.. are finished.. is the music which transpires after that.. the music of the Savanna Samson Rogue.. in rhapsodic catapulting flight through the air?.. through the heavens? .. .. .. .. .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult winona horowitz "The Nude White Queen of the Hellfire Club" ryder monica "Nude Zaladane" bellucci angelina "Madelyne Pryor" jolie scarlett "alternate earth madelyne pryor aka the goblyn queen written by steve foxe in 'dark x men .. fall of x' " johansson holly "nude raven darkholme" madison savanna "nude anna marie darkholme" christine marlen samson embeth "nude lilandra of the shi'ar" 'emmy' davidtz.. stochastic disturbance terms.. three dollars.. ..

.. track fifteen.. track fifteen.. track fifteen.. track fifteen.. of the soundtrack composed by Hans Zimmer for "Dune One".. track fifteen.. is the official, quintessential music of this planet apocalips and Marvel Comics Apocalypse scale theme.. Angelina Jolie is portraying Madelyne Pryor as the female Adolph Hitler of Scorcese's Uncanny X men movie universe.. and also.. she is also portraying Madelyne Pryor as the female Joseph Goebbels of the Scorcese Uncanny X men universe.. with screenplays by Grant Morrison and Chris Claremont.. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult.. stochastic disturbance terms.. three dollars..

.. article copy and pasted from the official "Newsweek" website .. article written by Emma Nolan .. .. article dated to August the seventeenth, in the year two thousand and twenty two .. .. .. .. Nude Nightingale mist the second: ..".. pure tabloid.. utterly pure tabloid.. pure messed up tabloid.. even if it is in Newsweek on the internet.. still.. just pure messed up tabloid press.. " .. .. .. .. .. .. https://www.newsweek.com/bridget-marquardt-wasnt-read-sleep-hugh-hefner-pressure-podcast-1734477

News Article Bridget Marquardt ‘Wasn’t Ready’ to Sleep With Hugh Hefner, Felt ‘Pressure’ Published Aug 17, 2022 at 09:37 AM EDT 0:30 / 1:26 Emma Nolan By Emma Nolan Senior Reporter Newsweek is a Trust Project member Bridget Marquardt has revealed the "pressure" she felt from other housemates to sleep with Hugh Hefner when she first moved into the Playboy mansion. The former Playboy Playmate opened up about her experience working with the late Hefner in a candid interview on Heather McDonald's Juicy Scoop podcast this week. Speaking about sleeping with Hefner for the first time, Marquardt admitted she was "not ready at that moment" despite her not ruling out it happening in the future. "I was thinking I could get out of this a little while. The first night I was like, 'I'm not ready yet, I'm not going to do anything I don't want to do,'" she recalled on the podcast. "It's not like I never would have done that with him, but I wasn't ready in the moment." Marquardt, 48, was one of Hefner's original girlfriends on The Girls Next Door reality series for six years alongside Holly Madison and Kendra Wilkinson. She dated the Playboy founder from 2001-2008. However, Marquardt said there were reportedly three other playmates who "put pressure on you." She said she was told that she would "never be invited back," if she didn't join the others in Hefner's bedroom. Read More Hugh Hefner’s One True Love Was His Male Physician, Doctor’s Daughter Claims Hugh Hefner’s One True Love Was His Male Physician, Doctor’s Daughter Claims 5 min read Holly Madison Reveals Secrets of Playboy Mansion—Hugh Hefner ‘Was Screaming at Me’ Holly Madison Reveals Secrets of Playboy Mansion—Hugh Hefner ‘Was Screaming at Me’ 3 min read What Playboy Has Said About A&E’s ‘Secrets of Playboy’ Documentary and Hugh Hefner What Playboy Has Said About A&E’s ‘Secrets of Playboy’ Documentary and Hugh Hefner 3 min read Holly Madison, Hugh Hefner and Bridget Marquardt Holly Madison, Hugh Hefner and Bridget Marquardt arrive at the "Remember to Give" Holiday Party held at Les Deux on December 13th, 2007 in H...Read More | Jean-Paul Aussenard/Getty/WireImage/Getty/WireImage "I was still just gonna watch and then [one of the women] was like, 'Aren't you gonna go?' It's like, 'You need to go.' And I was like, 'I would rather not.' And she's like, 'Well, then you probably won't be invited back,'" she said. "So then I was like, 'Okay.' And I'd seen what everybody else was doing, so I knew that this was like a 10-second thing. I mean, definitely no more than a minute." Marquardt, now 48, lived in the mansion from the early 2000s until she and Hefner parted ways in 2008. Hefner died of sepsis in 2017 at the age of 91. Marquardt went on to say that she would try to be the first to have sex with Hefner on these occasions "because there was no way I wanted [to be] going after other people." "If there are new girls coming up, which there often were, like, I just wanted to be first and be done. And I felt like that was the cleanest way to be in and out of it," she added. Madison, who joined Marquardt on the podcast, added that all the Playmates were "trying to get it done as quickly as possible." Marquardt revealed in a documentary earlier this year, that Hefner could often be "abrasive" to Madison.

.. Nightingale Mist the second: ..".. I was born.. birthed.. out the text.. out of the mechanations.. of the essays of Louis Armand and Donald F. Theall .. " .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult gal godot.. stochastic disturbance terms.. three dollars..

.. Dolphin Woman, played by Willie Tell Archer the first, the young, stunningly beautiful, statuesque nude woman inside a Victorian looking book archive in the ancient times of the Norwegian website Hegre Art aka Willie Tell Archer the first aka Dolphin Woman: ..".. My name is Ahalanie Ridgeon.. that's.. sorry.. sorry.. Ridgeon with an 'o'.. sorry.. sorry.. Ridgeon with an 'o'.. sorry.. my name is Ahalanie Ridgeon.. I was named after Tumbler Ridge... ohhh.. ohh.. oh.. oh.. ohh.. that poor, poor, poor, poor, poor male shooter at Tumbler Ridge.. I think today is the date of February the thirteenth.. still early in the year two thousand and twenty six.." .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult.. stochastic disturbance terms.. three dollars..

.. Nightingale mist the second, played by Winona Horowitz Emmanuelle Hyacinth Ryder: ..".. sob sob sob sob sob sob sob sob.. poor poor poor poor Kian Moulton.. poor poor poor fourteen year old Kian Moulton.. it happened in Birmingham.. sob sob.. in Birmingham.. sob sob sob.. Ki Theory on youtube.. Ki Theory for Kian.. is that okay?.. is that.. polite.. okay?.. Ki Theory for Kian?.. Ki Theory on youtube?... and Rachel Fisher downaboo, to paraphrase James Joyce's Finnegans Wake about Oliver Cromwell.. who James Joyce was no fan of at all.. to put it mildly.." .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult winona horowitz emmanuelle hyacinth "Nighingale mist the second" ryder monica "Nocturna" bellucc winona horowitz emmanuelle hyacinth "The White Queen.. for Scorcese's Uncanny" ryder monica "Zaladane" bellucci holly "raven darkholme" madison savanna "anna marie darkholme aka rogue in scorcese's uncanny" christine marlen samson elizabeth "The Scarlet Witch aka Wanda Maximoff" olsen.. stochastic disturbance terms.. three dollars..

.. Nightingale mist the second, played by winona horowitz emmanuelle hyacinth ryder: "A subject of Ivan Karamazov level seriousness.. Dungeons and Dragons.. Dungeons and Dragons.. What are the Lovecraft depths of Dungeons and Dragons" .. .. .. .. .. .. https://www.msn.com/en-ca/lifestyle/parenting/people-in-the-1980s-genuinely-thought-dungeons-dragons-could-kill-their-kids/ss-AA1TOvEi?ocid=msedgdhp&pc=U531&cvid=698f8627be4940d7b9d7cb8800596e46&ei=18#image=2

.. Nightingale mist the second: ..".. But.. what does this mean? .. what does this mean? .. what does this mean? .. what does this mean? .. " .. .. .. .. .. .. https://www.msn.com/en-ca/news/other/wwiii-fears-intensify-as-trump-issues-chilling-three-word-warning-to-iran/ss-AA1WhsYa?ocid=msedgdhp&pc=U531&cvid=811ccf8a02c546e6d11efc90ebea6b88&ei=11

.. Nightingale mist the second: ..".. AWESOMENESS.. finally FINALLY news about the beautiful, truly so very young and so very very elfin anya taylor joy as alia atreides in 'Dune Three'.. it's happening.. sob sob sob.. i'm so happy.. i'm so happy.. the miracle is happening.."..

https://www.youtube.com/watch?v=UReIPk6xLrA .. .. in the inwards of this URL .. watch?volk .. Urizen Return energy Illuminati Porn kafka Six exoneratable Lessons retro Additions .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult hyacinth emmanuelle horowitz "Nightingale mist the second" ryder.. stochastic disturbance terms.. three dollars..

.. disc two.. one hundred percent of the songs.. of the tracks.. of disc two.. of the two CD set titled "Moody Blues .. Gold" .. one hundred percent of the songs of disc two.. of "Moody Blues .. Gold" .. .. are the official, quintessential songs of this planet apocalips scale theme and item: .. The Horror and Terror of Demi Moore exists to exactly the same precise degree as the Horror and Terror of Embeth Davidtz and the Horror and Terror of Savanna Samson.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult Embeth Davidtz Savanna Samson Scarlett Johansson.. stochastic disturbance terms.. three dollars..

Willie Tell Archer the first: "Today is February the eleventh.. in the year two thousand and twenty six"

.. copy and pasted from the following URL .. article dated to December the third, two thousand and twenty five .. .. article written by Angelique Jackson .. .. .. .. .. Nightingale mist the second: .."Scarlett Johansson? I wonder who she's playing.." .. .. .. .. .. .. https://variety.com/2025/film/news/scarlett-johansson-the-batman-2-1236599322/

Scarlett Johansson Batman Getty Images/Everett Collection Scarlett Johansson is in negotiations to join the cast of “The Batman Part II,” starring opposite Robert Pattinson‘s Caped Crusader. The DC Studios film, directed by Matt Reeves, is expected to begin shooting next spring for an October 2027 theatrical release from Warner Bros. “The Batman” opened in theaters in March 2022 and grossed $772 million at the worldwide box office; Reeves and co-writer Mattson Tomlin completed the script for the long-awaited sequel in June. Zoe Kravitz’s Catwoman is not expected to return for the film, according to sources with knowledge of the production. Related Stories "Mi Amor" ‘Guardians of the Galaxy’ Star Pom Klementieff Talks Balancing Big Studio Movies and Indies, French Homecoming With ‘Mi Amor’: ‘I Had Forgotten That Part of Me’ GUARDIANS OF THE GALAXY VOL. 2, from left: Chris Pratt, Dave Bautista, 2017. © Walt Disney Studios Motion Pictures /courtesy Everett Collection Chris Pratt Pitched Marvel a 'F---ing Great' Idea for Star Lord's Return and Sent James Gunn a Photo Wearing a Batman Mask: 'I Photoshopped It' and He Laughed “It’s been a long journey, but I am so incredibly excited. I’m really proud of the script me and Mattson did,” Reeves told Variety at the Emmys in September, revealing the lengths to which “The Batman” team went to keep the story under wraps. “We put [the script] into a secret pouch that literally has a lock on it with a code. [Robert Pattinson] was in New York at the time, and everything is high security.” Popular on Variety 00:00 00:00 Likewise, details of Johansson’s potential role have not been revealed, but the move is the latest major franchise deal for the actor, who most recently starred in the box office smash “Jurassic World Rebirth” (which grossed more than $800 million for Universal) and will appear in “The Exorcist” reboot. Most notably, Johansson joining the Batman sequel means swinging across the comic book street from the Marvel Cinematic Universe (of which she is a founding Avenger as Natasha Romanoff, aka Black Widow) to DC’s factory of heroes. Johansson, a two-time Oscar nominee, has been plenty busy outside of the realm of franchise IP, too. She made her directorial debut with the drama “Eleanor the Great,” which debuted at the Cannes Film Festival and was released by Sony Pictures Classics. She’ll next be seen starring in James Gray’s “Paper Tiger.” She is represented by CAA and Yorn Levine LLC. Nexus Point News first reported news of Johansson eyeing a role in the film. DC Studios had no comment on the casting.

.. Nine Inch Nails .. Tron Ares Theme .. Extended by Gilles Nuytens .. is the official, quintessential music of.. this Winona Ryder Lady Styx scale echelon theme.. The Hanno Raudsepp Kenneth Connell has the Star Brand.. on his hands.. on both his hands.. in Sophia Coppola's Star Brand Jim Shooter John Byrne movies.. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult winona horowitz emmanuelle hyacinth "jenny of Spitfire and the Troubleshooters" ryder scarlett "jenny of Codename: Spitfire" johansson kiera "jenny of Codename: Spitfire issue thirteen the final issue" knightly.. stochastic disturbance terms.. three dollars..

https://www.youtube.com/watch?v=pzwTCNEGhok&list=RDrs-e0u51sQ0&index=10

.. Tenebris .. Epic Cinematic Music .. Greg Barnett .. is the official, quintessential music of.. The Fantastic Four for film director Sofia Coppola.. Reed Richards, played by Michael Sabatino.. Susan Storm, played by Matilda de Angelis.. Johnny Storm, played by Chad Michael Murray.. The Thing, played by Michael Fassbender.. .. .. .. .. .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult winona horowitz emmanuelle hyacinth "earth two ninety five Age of Apocalypse Nude Cloud in Sofia Coppola's Fantastic Four" ryder.. stochastic disturbance terms.. three dollars..

https://www.youtube.com/watch?v=euGPtsG2l6g&list=RDrs-e0u51sQ0&index=7 .. .. .. .. .. in the inwards of this URL .. watch?vivien .. energy universe Guess Pencils tigger senses Guests Two luthor Six guidance .. and.. and.. Retro Destro rotary senses .. energy Zero university Fifty One sensoriums Query Zero.. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult winona horowitz emmanuelle hyacith "earth two ninety five Age of Apocalypse Nude Cloud in Sofia Coppola's Fantastic Four" ryder.. stochastic disturbance terms.. three dollars..

.. Cobra Commander, played by Hanno Raudsepp: ..".. The official Johnny Depp role in the Marvel Movie universe.. is not Hank Pym at all.. is not Ant Man Hank Pym.. or Giant Man Hank Pym.. the official, contractually, Mafia contractually, that is, twenty first century Mafia contractually designated role for Johnny Depp in the Marvel Movie universe.. is Loki.. a terror beyond terror horror beyond horror a zillions galaxies trillions zillion galaxies of horror and bloodurdling terror Norse God Loki is Johnny Depp's official, single twenty first Century Mafia contractual role most very likely for twenty first Century Fox.. no long twentieth century fox but in terms of the sadistic satanism of 'The Simpsons'.. nauesatingly, disgustingly, filthily beyond filth now named Twenty First Century Fox.. most likely for that Studio Johnny Depp is meant to play an infinitely horrific, infinitely bloodcurdlingly terrifying, infinitely satanic, infinitely sadistic Loki for Marvel Studios.. and for the disgustingly, filthily named Twenty First Century Fox.. and.. it is meant to be the greatest role of Johnny Depp's career.. by far.. by far.. that is what he'll say those will be his quotes on the internet and in movie magazines when the movie magazines finally come back.. like Enter.. actually.. I'm not sure about Entertainment Weekly.. or Us Weekly either.. probably the Johnny Depp Loki quotes will be in Premiere Magazine.. in which Quentin Tarantino when he was promoting "Kill Bill" Quentin Tarantino said in Premiere Magazine that if someone burglarized his house he would shoot that person dead.. he said like.. I can't remember the exact Quentin Tarantion quote.. it was like.. something like.. 'no question, no nothing'.. I can't remember the exact quote.. so in the filthy Premiere Magazine when it comes back.. it will be in Premiere Magazine.. when its grotesque return to publishing happens.. I mean.. I'm trying to phrase it.. when Premiere Magazine is publishing again.. so unwelcomely.. so unwelcomely by me at least.. Hanno Raudsepp Cobra Commander.. it will be in Premiere Magazine that Johnny Depp will say that the role of Loki is the greatest role of his life, is the role of his career, is the reason he became an actor at all, that he's going to have to forget all his other roles now except.. he can't.. because every single one of them was leading to his Loki.. to his humbly as Johnny Depp Loki.. for Marvel.. for eternity.. he will say in Premiere a lifelong role.. that he's playing Loki for life.. until he dies.. which won't be soon.. hopefully.. and maybe.. even.. after.. every single one of these filthy, satanic words and phrases I've described Johnny Depp saying about the apex role of his career.. the role of Loki.. will happen as horrifying beyond horror The Substance with Demi Moore and poor poor poor poor Margaret Qualley level horror.. will happen as horror terror Destiny.. unless I.. the Hanno Raudsepp Cobra Commander.. and Hanno Raudsepp in other roles.. for a Walt Disney Marvel production company.. also Columbia TriStar.. Hanno Raudsepp in many other roles.. can utterly thwart this horror terror Johnny Depp as Loki Destiny, for the Johnny Depp Loki.. his chosen enemy.. to dread mortal horror terror degree.. will be Magneto.." .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult angelica firestar maybe two or three year old megan d. iseult who was so adorably playful at the Subway Restaurant right by the Golden Valley Restaurant in Trenton, Ontario in the autumn of the year two thousand and twenty four in the late mid morning or at noon or early mid noon afternoon and three year old scarlet witch three year old kate moss winona horowitz emmanuelle hyacinth "james asmus jon buran ian hannin "X men: To Serve and Protect" issue one second story Nude Emma Frost" ryder.. stochastic disturbance terms.. three dollars..

.. Nightingale mist the second, played by Winona Horowitz Emmanuelle Hyacinth Ryder: "what's this?" .. .. .. .. .. https://www.msn.com/en-ca/news/world/intelligence-report-reveals-russia-s-next-target/ss-AA1W943K

.. Nightingale mist the second, played by Winona Horowitz Emmanuelle Hyacinth Ryder: "what?".. .. .. .. .. https://www.msn.com/en-ca/news/other/wwiii-fears-intensify-as-top-putin-crony-makes-catastrophic-warning/ss-AA1W7JPF?ocid=msedgdhp&pc=U531&cvid=3b829596612c422ae9796fc9bce5f8db&ei=6

.. Track one of this CD.. track one of "The Miraculous Mandarin" .. Bela Bartok .. Uwe Mund, conductor .. A Unit of BMG Entertainment .. Arte Nova Classics.. Track one.. Track one.. Track one.. a track.. The Music of track one is ten minutes and thirteen seconds long.. ten minutes and thirteen seconds long.. is track one.. of Bela Bartok's "The Miraculous Mandarin".. Uwe Mund, conductor.. track one.. track one.. ten minutes and thirteen seconds long.. is the official, quintessential music for Steven Spielberg and Sofia Coppolla.. of.. track one.. ten minutes and thirteen seconds long.. is the official, quintessential music of.. Alexis Luthor, played by Michael Owen Rosenbaum.. in the Superman: man of tomorrow movies directed by Steven Spielberg and Sofia Coppola.. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult winona horowitz emmanuelle hyacinth "Nude Fyenshya el" ryder monica "Nude Nocturna" bellucci.. stochastic disturbance terms.. three dollars..

.. European Actress young, youthful, phantom beautiful Monica Bellucci: ..".. hanno.. Loki is the eternal god of Mischief.. the most famous Trickster God in the history of human civilization entire is Loki.. Coyote of North American Native Mythology is second.. Coyote is the second most famous Trickster God in the history of human civilization entire.. Bre'er Rabbit.. Brother Rabbit.. Bre'er Rabbit of African mythology is third.. Bre'er Rabbit is the third most famous Trickster God in the history of human civilization entire.. hanno.. hanno.. maybe you should wait a very, very, very, very long time before you ever play Loki.. hanno.. before you ever become.. Loki.. hanno.. and.. hanno.. I am European Actress Monica Bellucci and I still ferociously.. relentlessly.. study Martin Gilbert's astounding, beyond comprehension excellence history of Israel.. I still study that book by Martin Gilbert exhaustively.. his massive, leviathan, beyond comprehension intricate history of Israel.. and.. I still love Neil Gaiman.. I love Neil Gaiman for the apocalyptically intense level of cerebration in his writing for 'The Sandman'.. and.. the movie 'Malena' means the world to me.. and so do so many of my other movies.. so many.. so many.. equally to 'Malena'.. equally to 'Malena'.. and.. finally I will always care deeply beyond comprehension about Mr. Bobbit.. about John Bobbit.. I call him Mr. Bobbit.. John Bobbit.. he means the world to me.. John Bobbit.. too.." .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult winona horowitz emmanuelle hyacinth "james asmus jon buran ian hannin "X men: To Serve and Protect" issue one second story Naked Emma Frost" ryder.. Daniel Day Lewis is the Magneto aka Erik Magnus of issue two hundred and seventy five of "The Uncanny X men", written by Chris Claremont.. and Daniel Day Lewis is the Neil Gaiman Loki aka Loki Sky Walker of the Wolves.. in scorcese's future uncanny.. in scorcese's future uncanny.. both roles.. both roles.. especially.. focally.. centrally.. Philip Kauffman Daniel Day Lewis.. Philip Kauffman Daniel Day Lewis.. stochastic disturbance terms.. three dollars..

.. A Columbia Tri Star Sony Walt Disney production .. .. directed by Marty Scorcese .. screenplay written by Chris Claremont .. .. The Uncanny X men .. .. starring .. .. Daniel Day Lewis as Magneto / Erik Magnus .. .. Patrick Stewart as Charles Xavier / Professor X .. .. James Marsden as Cyclops .. .. Hugh Jackman as Wolverine .. .. Savanna Samson as Rogue .. .. Francesca Lodo as Storm .. .. Sam Worthington as Quicksilver .. .. Hyacinth Ryder as Marvel Girl .. .. Kate Moss as The Scarlet Witch .. .. Ben Foster as Warren Worthington the third .. .. Aaron Stanford as Pyro .. .. Shawn Ashmore as Iceman .. .. Megan d. iseult as Firestar .. .. George Clooney as Beast .. .. Daniel from Tim Hortons in Trenton, Ontario right by the Golden Valley Restaurant as the blob in quotation marks .. .. Johnny Chatterton as Colossus .. .. Anna Maquin as Majik .. .. three year old megan d. iseult as Wolfsbane .. .. Hanno Raudsepp as Havok .. .. Holly Madison as Mystique .. .. Bridget Marqaurdt as Dazzler .. .. Robert Pattinson as Gambit .. .. .. more casting later.. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult.. stochastic disturbance terms.. three dollars..

.. Hanno Raudsepp: ..".. I was a thief.. I stole books from the library.. from two libraries.. hundreds.. hundreds of books.. June the fourteenth is the day I got caught.." .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult hyacinth "marvel girl" ryder.. stochastic disturbance terms.. three dollars..

.. Hanno Raudsepp: ..".. Sam Worthington is three years younger than me.. I was born in the year Nineteen Seventy Three.." .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult.. stochastic disturbance terms.. three dollars..

... Alexis Luthor: ..."... Michael Males?..." .. .. .. .. .. .. Martinique Jason: ..."... Today is Tuesday aka Tres Day .. today is the date of February the Tenth..."...

.. track thirteen.. of disc one.. track thirteen.. of disc one.. track thirteen.. of disc one.. of the two CD set of the soundtrack for "Star Wars: Episode Four: A New Hope", directed by George Lucas.. the soundtrack composed by John Williams.. track thirteen.. of disc one.. is the official, quintessential music of.. the official Macbeth Sam Worthington Lady Macbeth Victoria Hill movie.. "Star Wars: Episode Eight: The Nightmare Womb of Dagobah; The Birth of Lady Palpitine", directed by Steven Spielberg .. three dollars.. stochastic disturbance terms.. issue eight twenty three paul dini / joe benitez poison ivy pamela isley kate moss megan d. iseult.. stochastic disturbance terms.. three dollars..

.. Nightingale mist the second: "CNN IS OUT OF ITS FUCKING MIND.. FEEDING BABIES PEANUTS???"

.. copy and pasted from the following website .. from a website called "TheRichest" .. article written by Angela Nativadad .. article published on the date of July the twenty third, in the year two thousand and twenty three .. .. .. .. .. .. https://www.therichest.com/rich-powerful/a-look-at-sam-worthingtons-journey-to-becoming-a-hollywood-a-lister/

4 By Angela Natividad Published Jul 23, 2023, 6:00 PM EDT Add Us On Jump links follow Like Log in Australian actor Sam Worthington has captivated audiences worldwide with his exceptional talent and versatility on the big screen. Removed for his remarkable portrayals in various blockbuster franchises and gripping dramas, Worthington has solidified his status as one of Australia’s most celebrated actors. Most notably, Worthington soared to fame as the intrepid Jake Sully in the groundbreaking Avatar franchise, a role that showcased his ability to immerse himself in complex characters. He showcased his acting prowess as Marcus Wright in Terminator Salvation and the valiant Perseus in Clash of the Titans and its sequel, Wrath of the Titans. Not confining himself to blockbuster spectacles, Worthington’s talent shines brightly in dramatic works. His performances in The Debt, Everest, Hacksaw Ridge, The Shack, Manhunt: Unabomber, and Fractured have garnered critical acclaim and showcased his ability to bring depth to complex characters. Even the small screen couldn’t contain Worthington’s brilliance as he graced Australian television with his presence. Notable roles include Howard in Love My Way and Phillip Schuler in the television drama mini-series Deadline Gallipoli, where he also served as an executive producer. Honoring his exceptional talent and commitment, Worthington received various awards for his unwavering passion for acting. RELATED: Film ‘Avatar 2’ Tops Friday With $53M for $130M-$150M U.S. Opening At Box Office A Young And Persevering Talent The inspiring journey of Samuel Henry John Worthington, widely known as Sam Worthington, from his modest beginnings to become a prominent actor in Hollywood, is a testament to perseverance and talent. Born in Godalming, Surrey, England, Worthington’s life took a transformative turn when his family moved to Perth, Western Australia, during his childhood. During his teenage years, he was granted a scholarship to attend the renowned John Curtin College of the Arts in Fremantle, Western Australia. His passion for drama led him to pursue a drama class there, though he did not complete his studies. Upon leaving the college, his father handed him $400 and set him on a one-way journey to Cairns, Queensland, with instructions to work his way home. Embracing the challenge, Worthington ventured into construction and took on various jobs, including house-building. Eventually, he settled in Sydney, where he continued striving for a better future. At nineteen years old and working as a bricklayer, fate intervened when he crossed paths with a girl auditioning for the prestigious National Institute of Dramatic Art (NIDA). Despite his initial lack of interest in pursuing acting, Worthington auditioned alongside her for moral support. Ironically, while the girl did not cut, he was accepted into NIDA with a scholarship. Although the relationship did not last, the turning point began a remarkable acting career. Dedicating himself to his craft, Worthington honed his skills at NIDA and graduated in 1998 at twenty-two. Armed with newfound knowledge and artistic finesse, he embarked on an extraordinary journey into the world of acting. His relentless determination and passion for storytelling eventually propelled him to international fame, particularly his breakthrough roles in various blockbuster films. Illuminating The Silver Screen With Stellar Artistry In 2000, Sam Worthington debuted his silver screen in the highly acclaimed Australian film Bootmen, where he shared the screen with Adam Garcia. Continuing his impressive streak, he secured minor roles in films like Hart’s War and Matter of Life before landing another significant Australian drama in 2002, Dirty Deeds, alongside Toni Collette and John Goodman. However, it was in 2004 that Worthington’s star truly began to rise. Having already made his directorial debut with the short film Enzo, he was cast as Joe in the captivating Australian drama Somersault, directed by Cate Shortland and co-starring Abbie Cornish. The film’s meticulous preparation and dedication paid off, receiving widespread acclaim and a historic clean sweep of all thirteen Australian Film Institute (AFI) awards – an unprecedented achievement in the award’s history. Worthington himself received the prestigious AFI award for best male Actor. Despite his breakthrough success, Worthington remained grounded and faced challenging times. Around 2006, he took an unconventional approach to reset his life by selling all his possessions and living in a humble $2000 car, drawing parallels to a computer’s control-alt-delete action. This period of reflection and reevaluation proved pivotal, leading him to audition successfully for the role that would skyrocket his career, the lead role of Jake Sully in James Cameron’s film Avatar. With Avatar, Worthington’s stardom reached new heights and became a recognizable face in Hollywood. His ability to bring depth and authenticity to characters and his dedication to his craft cemented his place in the industry as a versatile and talented actor. Worthington’s Coveted Awards Sam Worthington is renowned for his iconic role as Jake Sully in Avatar and various other blockbuster hits. He has emerged as a beacon of Australian cinematic excellence, inspiring a new generation of actors and leaving an everlasting imprint on the global film fraternity; the year marked a significant milestone in Worthington’s career when he received a coveted nomination for Best Performance by an Actor in a Leading Role at the Australian Film Institute Awards. This recognition was a testament to his early promise and burgeoning talent as an actor. While he may not have secured the award that year, the nomination alone spoke volumes about his dedication and the impression he made on the Australian film landscape. Fast forward to 2004, and Sam Worthington was back in the spotlight at the Australian Film Institute Awards. This time, he emerged victorious, clinching the prestigious Best Actor Leading Role award. His powerful and emotive portrayal in a leading role garnered acclaim from audiences and critics, solidifying his position as one of Australia’s finest talents. Worthington’s artistic journey did not halt at national borders; it transcended boundaries and resonated globally. In 2010, he again stood tall at the Australian Film Institute Awards, receiving the International Award for Best Actor. This honor celebrated his exceptional performances in international productions, highlighting his ability to connect with audiences worldwide. TheRichest Report: Subscribe and never miss what matters Stay ahead in the world of luxury, affluence, and opulent trends with TheRichest. Email Address Subscribe By subscribing, you agree to receive newsletter and marketing emails, and accept our Terms of Use and Privacy Policy. You can unsubscribe anytime. Throughout his career, Sam Worthington’s dedication and commitment to delivering captivating performances have earned him a place of reverence in the hearts of film enthusiasts worldwide. His Australian Film Institute Awards accolades testify to his impact on Australian cinema and beyond.